biopharmaapac.com Open in urlscan Pro
2606:4700:3037::6815:6025 Public Scan

Go To Rescan
Add Verdict Report

Submitted URL:
https://t.dripemail2.com/c/eyJhbGciOiJIUzI1NiJ9.eyJhdWQiOiJkZXRvdXIiLCJpc3MiOiJtb25vbGl0aCIsInN1YiI6ImRldG91cl9saW5rIiwia...
Effective URL:
https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-...
Submission: On March 13 via api (March 13th 2024, 7:19:12 am UTC) from DE — Scanned from DE

Summary HTTP 77 Redirects Links 9 Behaviour Indicators

Summary

This website contacted 16 IPs in 2 countries across 13 domains to perform 77 HTTP transactions. The main IP is 2606:4700:3037::6815:6025, located in United States and belongs to CLOUDFLARENET, US. The main domain is biopharmaapac.com.
TLS certificate: Issued by GTS CA 1P5 on February 27th 2024. Valid for: 3 months.

This is the only time biopharmaapac.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

	IP Address	AS Autonomous System
1 1	34.238.102.32 34.238.102.32	14618 (AMAZON-AES) (AMAZON-AES)
32	2606:4700:303... 2606:4700:3037::6815:6025	13335 (CLOUDFLAR...) (CLOUDFLARENET)
8	2a00:1450:400... 2a00:1450:4001:80b::200e	15169 (GOOGLE) (GOOGLE)
2	2a00:1450:400... 2a00:1450:4001:80b::2003	15169 (GOOGLE) (GOOGLE)
10	2a00:1450:400... 2a00:1450:4001:80b::2004	15169 (GOOGLE) (GOOGLE)
2	199.232.188.157 199.232.188.157	54113 (FASTLY) (FASTLY)
1	2a00:1450:400... 2a00:1450:4001:80e::2008	15169 (GOOGLE) (GOOGLE)
1	2606:4700::68... 2606:4700::6810:5049	13335 (CLOUDFLAR...) (CLOUDFLARENET)
11	2a00:1450:400... 2a00:1450:4001:81c::2003	15169 (GOOGLE) (GOOGLE)
1 2	2a00:1450:400... 2a00:1450:4001:829::2002	15169 (GOOGLE) (GOOGLE)
1	2a00:1450:400... 2a00:1450:4001:828::2006	15169 (GOOGLE) (GOOGLE)
4	2a00:1450:400... 2a00:1450:4001:802::200a	15169 (GOOGLE) (GOOGLE)
1	2a00:1450:400... 2a00:1450:4001:82a::2016	15169 (GOOGLE) (GOOGLE)
1	2001:4860:480... 2001:4860:4802:32::36	15169 (GOOGLE) (GOOGLE)
1	2a00:1450:400... 2a00:1450:4001:811::2001	15169 (GOOGLE) (GOOGLE)
1	104.244.42.8 104.244.42.8	13414 (TWITTER) (TWITTER)
77	16

1 34.238.102.32 (Ashburn, United States) 1 redirects

ASN14618 (AMAZON-AES, US)
PTR: ec2-34-238-102-32.compute-1.amazonaws.com

t.dripemail2.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

32 2606:4700:3037::6815:6025 (United States)

ASN13335 (CLOUDFLARENET, US)

biopharmaapac.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

8 2a00:1450:4001:80b::200e (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

www.youtube.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 2a00:1450:4001:80b::2003 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

fonts.gstatic.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

10 2a00:1450:4001:80b::2004 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

www.google.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 199.232.188.157 (Munich, Germany)

ASN54113 (FASTLY, US)

platform.twitter.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a00:1450:4001:80e::2008 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

www.googletagmanager.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2606:4700::6810:5049 (United States)

ASN13335 (CLOUDFLARENET, US)

static.cloudflareinsights.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

11 2a00:1450:4001:81c::2003 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

www.gstatic.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 2a00:1450:4001:829::2002 (Frankfurt am Main, Germany) 1 redirects

ASN15169 (GOOGLE, US)

googleads.g.doubleclick.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a00:1450:4001:828::2006 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

static.doubleclick.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

4 2a00:1450:4001:802::200a (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

jnn-pa.googleapis.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a00:1450:4001:82a::2016 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

i.ytimg.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2001:4860:4802:32::36 (United States)

ASN15169 (GOOGLE, US)

region1.google-analytics.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a00:1450:4001:811::2001 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

yt3.ggpht.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 104.244.42.8 (United States)

ASN13414 (TWITTER, US)

syndication.twitter.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

	Apex Domain Subdomains	Transfer
32	biopharmaapac.com biopharmaapac.com	2 MB
13	gstatic.com fonts.gstatic.com www.gstatic.com	1 MB
10	google.com www.google.com — Cisco Umbrella Rank: 2	96 KB
8	youtube.com www.youtube.com — Cisco Umbrella Rank: 66	1013 KB
4	googleapis.com jnn-pa.googleapis.com — Cisco Umbrella Rank: 218	41 KB
3	doubleclick.net 1 redirects googleads.g.doubleclick.net — Cisco Umbrella Rank: 35 static.doubleclick.net — Cisco Umbrella Rank: 259	1 KB
3	twitter.com platform.twitter.com — Cisco Umbrella Rank: 1306 syndication.twitter.com — Cisco Umbrella Rank: 1683	131 KB
1	ggpht.com yt3.ggpht.com — Cisco Umbrella Rank: 231	2 KB
1	google-analytics.com region1.google-analytics.com — Cisco Umbrella Rank: 2089	255 B
1	ytimg.com i.ytimg.com — Cisco Umbrella Rank: 89	56 KB
1	cloudflareinsights.com static.cloudflareinsights.com — Cisco Umbrella Rank: 788	7 KB
1	googletagmanager.com www.googletagmanager.com — Cisco Umbrella Rank: 40	91 KB
1	dripemail2.com 1 redirects t.dripemail2.com — Cisco Umbrella Rank: 181280	276 B
77	13

	Domain	Requested by
32	biopharmaapac.com	biopharmaapac.com static.cloudflareinsights.com
11	www.gstatic.com	www.google.com www.youtube.com www.gstatic.com
10	www.google.com	biopharmaapac.com www.youtube.com www.gstatic.com www.google.com
8	www.youtube.com	biopharmaapac.com www.youtube.com
4	jnn-pa.googleapis.com	www.youtube.com
2	googleads.g.doubleclick.net	1 redirects www.youtube.com
2	platform.twitter.com	biopharmaapac.com platform.twitter.com
2	fonts.gstatic.com	www.youtube.com
1	syndication.twitter.com	platform.twitter.com
1	yt3.ggpht.com	www.youtube.com
1	region1.google-analytics.com	www.googletagmanager.com
1	i.ytimg.com	www.youtube.com
1	static.doubleclick.net	www.youtube.com
1	static.cloudflareinsights.com	biopharmaapac.com
1	www.googletagmanager.com	biopharmaapac.com
1	t.dripemail2.com	1 redirects
77	16

This site contains links to these domains. Also see Links.

Domain
www.ppd.com
explore.agilent.com
www.mastercontrol.com
cytiva.link
tinyurl.com
www.biopharmaapac.com
imapac.com
www.linkedin.com
twitter.com

Subject Issuer	Validity	Valid
biopharmaapac.com GTS CA 1P5	`2024-02-27` - `2024-05-27`	3 months	crt.sh
*.google.com GTS CA 1C3	`2024-02-19` - `2024-05-13`	3 months	crt.sh
*.gstatic.com GTS CA 1C3	`2024-02-19` - `2024-05-13`	3 months	crt.sh
www.google.com GTS CA 1C3	`2024-02-19` - `2024-05-13`	3 months	crt.sh
*.twimg.com DigiCert Global G2 TLS RSA SHA256 2020 CA1	`2023-07-21` - `2024-08-20`	a year	crt.sh
*.google-analytics.com GTS CA 1C3	`2024-02-19` - `2024-05-13`	3 months	crt.sh
cloudflareinsights.com GTS CA 1P5	`2024-03-10` - `2024-06-08`	3 months	crt.sh
*.doubleclick.net GTS CA 1C3	`2024-02-19` - `2024-05-13`	3 months	crt.sh
upload.video.google.com GTS CA 1C3	`2024-02-19` - `2024-05-13`	3 months	crt.sh
edgestatic.com GTS CA 1C3	`2024-02-19` - `2024-05-13`	3 months	crt.sh
*.googleusercontent.com GTS CA 1C3	`2024-02-19` - `2024-05-13`	3 months	crt.sh
syndication.twitter.com R3	`2024-02-21` - `2024-05-21`	3 months	crt.sh

This page contains 7 frames:

Primary Page: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren
Frame ID: 770B935813582FE68837C596A0985205
Requests: 38 HTTP requests in this frame

Frame: https://www.youtube.com/embed/lOcQEjAN7YU
Frame ID: EBDE9E473620ADE36419574A8F4E96B0
Requests: 20 HTTP requests in this frame

Frame: https://platform.twitter.com/widgets/widget_iframe.2f70fb173b9000da126c79afe2098f02.html?origin=https%3A%2F%2Fbiopharmaapac.com
Frame ID: 18CFF61305D88465F1232D2C0F8063A8
Requests: 2 HTTP requests in this frame

Frame: https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC&co=aHR0cHM6Ly9iaW9waGFybWFhcGFjLmNvbTo0NDM.&hl=de&v=QquE1_MNjnFHgZF4HPsEcf_2&size=normal&cb=ez6p3ml2ljab
Frame ID: A6A75517E78F3DC0E7366B39C0250DEC
Requests: 5 HTTP requests in this frame

Frame: https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC&co=aHR0cHM6Ly9iaW9waGFybWFhcGFjLmNvbTo0NDM.&hl=de&v=QquE1_MNjnFHgZF4HPsEcf_2&size=normal&cb=f20xznm3iu4s
Frame ID: C2CDB810212D16E63961D760C217C3BC
Requests: 5 HTTP requests in this frame

Frame: https://www.google.com/recaptcha/api2/bframe?hl=de&v=QquE1_MNjnFHgZF4HPsEcf_2&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC
Frame ID: A206919C78268AD72CE898AC1FB10697
Requests: 3 HTTP requests in this frame

Frame: https://www.google.com/recaptcha/api2/bframe?hl=de&v=QquE1_MNjnFHgZF4HPsEcf_2&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC
Frame ID: 9D16E3D533B505D236A35AB7A9ABF2BE
Requests: 3 HTTP requests in this frame

Screenshot
Live screenshot

Full Image

Page Title

CARsgen Therapeutics Receives NMPA Approval for Breakthrough Multiple Myeloma CAR T-Cell Therapy

Page URL History Show full URLs

https://t.dripemail2.com/c/eyJhbGciOiJIUzI1NiJ9.eyJhdWQiOiJkZXRvdXIiLCJpc3MiOiJtb25vbGl0aCIsInN1YiI6I... HTTP 307
https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-m... Page URL

Detected technologies

Bootstrap (Web Frameworks) Expand

Overall confidence: 100%
Detected patterns

<link[^>]* href=[^>]*?bootstrap(?:[^>]*?([0-9a-fA-F]{7,40}|[\d]+(?:.[\d]+(?:.[\d]+)?)?)|)[^>]*?(?:\.min)?\.css
bootstrap(?:[^>]*?([0-9a-fA-F]{7,40}|[\d]+(?:.[\d]+(?:.[\d]+)?)?)|)[^>]*?(?:\.min)?\.js

Cloudflare Browser Insights (Analytics) Expand

Overall confidence: 100%
Detected patterns

static\.cloudflareinsights\.com/beacon(?:\.min)?\.js

Font Awesome (Font Scripts) Expand

Overall confidence: 100%
Detected patterns

<link[^>]* href=[^>]+(?:([\d.]+)/)?(?:css/)?font-awesome(?:\.min)?\.css
<link[^>]* href=[^>]*?(?:F|f)o(?:n|r)t-?(?:A|a)wesome(?:[^>]*?([0-9a-fA-F]{7,40}|[\d]+(?:.[\d]+(?:.[\d]+)?)?)|)
(?:F|f)o(?:n|r)t-?(?:A|a)wesome(?:.*?([0-9a-fA-F]{7,40}|[\d]+(?:.[\d]+(?:.[\d]+)?)?)|)

Google Analytics (Analytics) Expand

Overall confidence: 100%
Detected patterns

Google Tag Manager (Tag Managers) Expand

Overall confidence: 100%
Detected patterns

googletagmanager\.com/gtag/js

Twitter (Widgets) Expand

Overall confidence: 100%
Detected patterns

//platform\.twitter\.com/widgets\.js

jQuery (JavaScript Libraries) Expand

Overall confidence: 100%
Detected patterns

jquery[.-]([\d.]*\d)[^/]*\.js
jquery.*\.js(?:\?ver(?:sion)?=([\d.]+))?

reCAPTCHA (Captchas) Expand

Overall confidence: 100%
Detected patterns

/recaptcha/api\.js

Page Statistics

77
Requests

99 %
HTTPS

81 %
IPv6

13
Domains

16
Subdomains

16
IPs

2
Countries

4512 kB
Transfer

9500 kB
Size

6
Cookies

9 Outgoing links

These are links going to different origins than the main page.

URL: https://www.ppd.com/our-solutions/clinical/functional-service-providers/

Search URL Search Domain Scan URL

URL: https://explore.agilent.com/magnis-ngs-automation

Search URL Search Domain Scan URL

URL: https://www.mastercontrol.com/resource-center/quality-manufacturing/pharma-industry-trends-2024/?utm_campaign=701PQ000006YF7eYAG&utm_medium=Online-Ads&utm_source=SI

Search URL Search Domain Scan URL

URL: https://cytiva.link/izqo4

Search URL Search Domain Scan URL

URL: https://tinyurl.com/494b3s7w

Search URL Search Domain Scan URL

URL: https://www.biopharmaapac.com/thermofisher-mediabydesign

Search URL Search Domain Scan URL

URL: https://imapac.com/events/clinical-trials-asia/

Search URL Search Domain Scan URL

URL: https://www.linkedin.com/company/biopharmaapac-news

Search URL Search Domain Scan URL

URL: https://twitter.com/BiopharmaApac

Search URL Search Domain Scan URL

Page URL History

This captures the URL locations of the websites, including HTTP redirects and client-side redirects via JavaScript or Meta fields.

https://t.dripemail2.com/c/eyJhbGciOiJIUzI1NiJ9.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.D1LDZzKnoYuHFU1wR0anO0G6nQlZQNd_sr0U3l8Xb7o HTTP 307
https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren Page URL

Redirected requests

There were HTTP redirect chains for the following requests:

Request Chain 42

https://googleads.g.doubleclick.net/pagead/id HTTP 302
https://googleads.g.doubleclick.net/pagead/id?slf_rd=1

77 HTTP transactions
1 data transactions

Method
Protocol Status Resource
Path Size
x-fer Time
Latency Type
MIME-Type IP
Location

GET
H2

200

Primary Request carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html Show response
biopharmaapac.com/news/134/4445/
Redirect Chain

https://t.dripemail2.com/c/eyJhbGciOiJIUzI1NiJ9.eyJhdWQiOiJkZXRvdXIiLCJpc3MiOiJtb25vbGl0aCIsInN1YiI6ImRldG91cl9saW5rIiwiaWF0IjoxNzA5NTIwMzM5LCJuYmYiOjE3MDk1MjAzMzksImFjY291bnRfaWQiOiI2MTU3NjEzIiwiZ...
https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=ema...

58 KB
14 KB

961ms
928ms

Document
text/html

2606:4700:3037::6815:6025
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3037::6815:6025 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare / PHP/7.0.33

Resource Hash

ff97e536f5a5a7dddc048ffc14b2be897a8bbaf6df5e38b0fdb87e954a8e1db7

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36
accept-language: de-DE,de;q=0.9

Response headers

alt-svc: h3=":443"; ma=86400
cache-control: no-cache
cf-cache-status: DYNAMIC
cf-ray: 863a40f859bd39bc-FRA
content-encoding: br
content-security-policy: upgrade-insecure-requests
content-type: text/html; charset=UTF-8
date: Wed, 13 Mar 2024 07:19:07 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
platform: hostinger
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=mzu36qbXOtvb0Z3x3DUnu0CKDd0S75wfNvqn%2Bn1kFGK4qc6zy80%2ByMt1%2BprXhrmpBzcLZTNfzIXYGQQqvAWyDEk8fiAigOq3vQgUm0Z60s%2Fp4yTaov%2BCm6XzUgLCYS%2F32%2F9AeTkOjiBeZr4mCV272g%3D%3D"}],"group":"cf-nel","max_age":604800}
server: cloudflare
vary: Accept-Encoding
x-powered-by: PHP/7.0.33
x-turbo-charged-by: LiteSpeed

Redirect headers

content-length: 0
date: Wed, 13 Mar 2024 07:19:06 GMT
location: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren

GET
H2 200 bootstrap.min.css
biopharmaapac.com/bundles/taai/app/site/css/ 157 KB
25 KB 30ms
28ms Stylesheet
text/css 2606:4700:3037::6815:6025
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://biopharmaapac.com/bundles/taai/app/site/css/bootstrap.min.css

Requested by

Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3037::6815:6025 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

f77c0d1739b618edc4a01ca3f6b2990b01a3009030af49ee8cf68e83052df194

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Wed, 13 Mar 2024 07:19:07 GMT
content-security-policy: upgrade-insecure-requests
content-encoding: br
cf-cache-status: HIT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age: 137811
alt-svc: h3=":443"; ma=86400
last-modified: Sun, 24 Dec 2023 14:35:33 GMT
server: cloudflare
etag: W/"27288-658841b5-c558fc44806ec9b6;br"
vary: Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=JtVGCKpJa8wSt%2BmOnoUvP0q%2BUx%2BVrZkU4yV1NjDdPtPAqFk18mCp7QKkst82XzOLTn5waA114QQSEby7r13ToGJTrueZAt4U6JyPbpIwC50FNV%2Bude1z9aaOMqLkQQ2IsN8Z1bWvSrnAdFHZW2aqhA%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: text/css
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
platform: hostinger
cf-ray: 863a40fe28e939bc-FRA
expires: Mon, 18 Mar 2024 17:02:16 GMT

GET
H2 200 style.css
biopharmaapac.com/bundles/taai/app/site/css/ 25 KB
6 KB 23ms
22ms Stylesheet
text/css 2606:4700:3037::6815:6025
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://biopharmaapac.com/bundles/taai/app/site/css/style.css

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3037::6815:6025 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

ebdc5cfff9a360616e819fbd3cb79de32c18c8cc9bf5fde761c69b015ccab1d5

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Wed, 13 Mar 2024 07:19:07 GMT
content-security-policy: upgrade-insecure-requests
content-encoding: br
cf-cache-status: HIT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age: 137811
alt-svc: h3=":443"; ma=86400
last-modified: Sun, 24 Dec 2023 14:35:33 GMT
server: cloudflare
etag: W/"6585-658841b5-d7545e5fc4eb3b36;br"
vary: Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=eqyPQwjTCR%2Bcy5QdbSvXqmNQBnT5rN9rJxTFEBCzfkVT%2BIc7p%2FNH3Rwf7AlPyocGrfv9ls5uS%2ByIdtPfBDqiJGQm6J6K7mm0o5avvQuvkD0Tm3gq6wAynljky4usDoinDGBRSLR8eASVr8kXEhrTtg%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: text/css
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
platform: hostinger
cf-ray: 863a40fe28ea39bc-FRA
expires: Mon, 18 Mar 2024 17:02:16 GMT

GET
H2 200 font-awesome.min.css
biopharmaapac.com/bundles/taai/app/site/css/ 20 KB
5 KB 32ms
31ms Stylesheet
text/css 2606:4700:3037::6815:6025
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://biopharmaapac.com/bundles/taai/app/site/css/font-awesome.min.css

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3037::6815:6025 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

b769324e0921f9f649611113e65f528ebae5e140da8a7e63c5d6ea7bc7a33bc0

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Wed, 13 Mar 2024 07:19:07 GMT
content-security-policy: upgrade-insecure-requests
content-encoding: br
cf-cache-status: HIT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age: 137811
alt-svc: h3=":443"; ma=86400
last-modified: Sun, 24 Dec 2023 14:35:33 GMT
server: cloudflare
etag: W/"511e-658841b5-37cf0363bbbb9110;br"
vary: Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=HHOZu91DVuMQICVyFxF7YWt5r0sj0hiO7uvc5YPoG96jxInq06isT7LlYm4YWvmYA%2FrTnloX1J8fFS2OIWNH4AIgxmPpfZsW7h7VIzW2pA1vbIW53z8764NyUkuP6YFYyPsJtO4RNhhbr2J9jtIGog%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: text/css
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
platform: hostinger
cf-ray: 863a40fe28ec39bc-FRA
expires: Mon, 18 Mar 2024 17:02:16 GMT

GET
H2 200 normalize.min.css
biopharmaapac.com/bundles/taai/app/site/css/ 2 KB
1 KB 24ms
23ms Stylesheet
text/css 2606:4700:3037::6815:6025
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://biopharmaapac.com/bundles/taai/app/site/css/normalize.min.css

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3037::6815:6025 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

b76ffbb2665f82b493e054b50d3d1bb3f2a8b4233be1795ca9937956eef196bc

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Wed, 13 Mar 2024 07:19:07 GMT
content-security-policy: upgrade-insecure-requests
content-encoding: br
cf-cache-status: HIT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age: 137811
alt-svc: h3=":443"; ma=86400
last-modified: Sun, 24 Dec 2023 14:35:33 GMT
server: cloudflare
etag: W/"897-658841b5-7766ac21e4fe004a;br"
vary: Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=iH5mwFQPCwix%2BNYd1mQEQNhZJ6%2FhcjJgny42gtm7142m5mNHH7ai%2FLQyHBVGNnnbKRDN1tA1E2kTRdQHa9cO98w%2FcuXeMnP3OBGlKCXMRt2lPx1JgZ8oBUrgTAQlZYO0vUZe02GIPuIaP6ZOfw0pjQ%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: text/css
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
platform: hostinger
cf-ray: 863a40fe28ed39bc-FRA
expires: Mon, 18 Mar 2024 17:02:16 GMT

GET
H2 200 custom-style.css
biopharmaapac.com/bundles/taai/app/site/css/ 342 B
565 B 21ms
20ms Stylesheet
text/css 2606:4700:3037::6815:6025
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://biopharmaapac.com/bundles/taai/app/site/css/custom-style.css

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3037::6815:6025 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

e65117229d77c2ee86fca1f8753df08d81434bf55569e574a03bcabce77ce436

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Wed, 13 Mar 2024 07:19:07 GMT
content-security-policy: upgrade-insecure-requests
content-encoding: br
cf-cache-status: HIT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age: 137811
alt-svc: h3=":443"; ma=86400
last-modified: Sun, 24 Dec 2023 14:35:33 GMT
server: cloudflare
etag: W/"156-658841b5-b5014e6d05cc6cea;br"
vary: Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=e945RUriHGYa0KFY5p7VjraKWf4WCXsm5rawiOjGrnBPy0xXuLu3KM0lHZSmEcacm8i71nX7C7r%2BtDF5w3wNNXAta9QunzV8B27f6TH7XHWFqaARSpphM5YhbE02FjleAyziuewGJAqAiXV8H%2FrzlQ%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: text/css
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
platform: hostinger
cf-ray: 863a40fe28ee39bc-FRA
expires: Mon, 18 Mar 2024 17:02:16 GMT

GET
H2 200 logo.jpg
biopharmaapac.com/bundles/taai/app/site/images/ 39 KB
39 KB 39ms
38ms Image
image/jpeg 2606:4700:3037::6815:6025
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://biopharmaapac.com/bundles/taai/app/site/images/logo.jpg

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3037::6815:6025 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

d997981b750d83dcba2e00d81538fec720b77fddf3862399d79beae42ca8659c

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Wed, 13 Mar 2024 07:19:07 GMT
content-security-policy: upgrade-insecure-requests
cf-cache-status: HIT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age: 176130
alt-svc: h3=":443"; ma=86400
content-length: 39791
last-modified: Sun, 24 Dec 2023 14:35:33 GMT
server: cloudflare
etag: "9b6f-658841b5-ae7fd8136fe2636a;;;"
vary: Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=P2T1urtm8mcAQpJQgBgTwn1CvbvfEteHz09QPnuIX0cpg3nRHOS8UslfFAF1FziY7uPPXZZNk7Fvle%2FFEtH7vPvZYwB9VB9jTjlEGDkaZ9cHBXk5hk5HBtTD0ffw6fY0mOpmNCOLIEJl0XhNNICC9A%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: image/jpeg
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
accept-ranges: bytes
platform: hostinger
cf-ray: 863a40fe28ef39bc-FRA
expires: Mon, 18 Mar 2024 06:23:36 GMT

GET
H2 200 lecm5ukcind2vop3ekloig-58.gif
biopharmaapac.com/uploads/static/ 48 KB
49 KB 25ms
24ms Image
image/gif 2606:4700:3037::6815:6025
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://biopharmaapac.com/uploads/static/lecm5ukcind2vop3ekloig-58.gif

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3037::6815:6025 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

3fc2e691e1187af7759ca69ec3dd411e759944a8de85babda28a77b0c7ec7f19

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Wed, 13 Mar 2024 07:19:07 GMT
content-security-policy: upgrade-insecure-requests
cf-cache-status: HIT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age: 137811
alt-svc: h3=":443"; ma=86400
content-length: 49320
last-modified: Fri, 01 Mar 2024 04:59:32 GMT
server: cloudflare
etag: "c0a8-65e160b4-d5eb46440014a061;;;"
vary: Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=70nrsVIMxMlWuYNTV1X4MX1GdsB%2BZkqvRPJYc5SXHweez0eWEgeQVYpDc2uGkKOwUztVG6whsr1oig1Fvu3eEPia8L4gj2Rqx2ZtOq29j5lzDyhMV3ZP2KDT3u4tP%2FoDInIiJERZ%2BcfzoMkO9b%2FLFg%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: image/gif
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
accept-ranges: bytes
platform: hostinger
cf-ray: 863a40fe28f139bc-FRA
expires: Mon, 18 Mar 2024 17:02:16 GMT

GET
H2 200 4243982983778988108-59.png
biopharmaapac.com/uploads/static/ 59 KB
59 KB 37ms
28ms Image
image/png 2606:4700:3037::6815:6025
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://biopharmaapac.com/uploads/static/4243982983778988108-59.png

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3037::6815:6025 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

b2f63e0bed940b3ad8d0fc2d93034d0ddc58d98dc40a818774c8aa91ba8c7b53

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Wed, 13 Mar 2024 07:19:07 GMT
content-security-policy: upgrade-insecure-requests
cf-cache-status: HIT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age: 426299
alt-svc: h3=":443"; ma=86400
content-length: 60073
last-modified: Wed, 31 Jan 2024 20:20:56 GMT
server: cloudflare
etag: "eaa9-65baaba8-950931d5436a3dfb;;;"
vary: Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=05BlqZdrs2R9UNuGA5HFlBYQFXQo14NhIIHu%2FjMVXCK61t1vRE0g12kqftlqQs%2F7Zd9U7jevavm%2FE2WBhhwkD2sdjg6qT5w6kVzr2rHh%2BrLSfzKnF0N1k8XJ9a0lT2RUQbqPs9OwbNzUCiCqCmrRNg%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: image/png
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
accept-ranges: bytes
platform: hostinger
cf-ray: 863a40fe390439bc-FRA
expires: Fri, 15 Mar 2024 08:54:08 GMT

GET
H2 200 human_cells_blue_background_766625_7673-4445.jpeg
biopharmaapac.com/uploads/articles/ 18 KB
18 KB 451ms
443ms Image
image/jpeg 2606:4700:3037::6815:6025
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://biopharmaapac.com/uploads/articles/human_cells_blue_background_766625_7673-4445.jpeg

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3037::6815:6025 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

2a6121880e5fb6f24e66f829b25b7f3d1567357bfb588913310922de7aa759a9

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Wed, 13 Mar 2024 07:19:07 GMT
content-security-policy: upgrade-insecure-requests
cf-cache-status: MISS
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
alt-svc: h3=":443"; ma=86400
content-length: 18516
last-modified: Sun, 03 Mar 2024 17:20:14 GMT
server: cloudflare
etag: "4854-65e4b14e-24fb469a0af67f15;;;"
vary: Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=jkdKArG24EPSCYYYgjY9dSr7GK6FpqjsHmbIgaln6xGd529cRjWh5bnBbirB1lXceFv1bOWh5z2HWC5kZqGEZq5WLPaIp896AHAYv3j%2FDknqI1tY%2Fhma%2F0ypwLX2bqzgjWkRZuqpn2rXga%2Bcx9JUew%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: image/jpeg
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
accept-ranges: bytes
platform: hostinger
cf-ray: 863a40fe390839bc-FRA
expires: Wed, 20 Mar 2024 07:19:07 GMT

GET
H2 200 24q1_pharma_tb_kop_banner_teal_opt_1_v1a_970x250-2105.png
biopharmaapac.com/uploads/static/ 102 KB
103 KB 37ms
29ms Image
image/png 2606:4700:3037::6815:6025
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://biopharmaapac.com/uploads/static/24q1_pharma_tb_kop_banner_teal_opt_1_v1a_970x250-2105.png

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3037::6815:6025 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

d86330a99574ad17d9e698df4dedca30b65def23e4a9483ae657b73fc2f11e95

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Wed, 13 Mar 2024 07:19:07 GMT
content-security-policy: upgrade-insecure-requests
cf-cache-status: HIT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age: 426298
alt-svc: h3=":443"; ma=86400
content-length: 104870
last-modified: Mon, 12 Feb 2024 16:36:14 GMT
server: cloudflare
etag: "199a6-65ca48fe-a2592b6b23048f6d;;;"
vary: Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=NUWYuums5edw3WaTJeFG3XY%2Fi%2B1yttDszkdWHOlxYm52xJtlyT58sqs1kIzYrdSVdNvW4Qh0MdYNCsdYOvDsRQ7lLrevqcHhbGTjF2FADH8Smc1Jphii8ZZHx8kyTl2KBB5symspRbswnHJWKxuidg%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: image/png
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
accept-ranges: bytes
platform: hostinger
cf-ray: 863a40fe390a39bc-FRA
expires: Fri, 15 Mar 2024 08:54:09 GMT

GET
H2 200 9_mab_still_a_programmatic_300x250-61.jpg
biopharmaapac.com/uploads/static/ 80 KB
80 KB 35ms
29ms Image
image/jpeg 2606:4700:3037::6815:6025
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://biopharmaapac.com/uploads/static/9_mab_still_a_programmatic_300x250-61.jpg

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3037::6815:6025 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

8a4b6d3305c9d1746d9a13a8d9eecb217d3f4b295a80c867add93eaddad17d8a

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Wed, 13 Mar 2024 07:19:07 GMT
content-security-policy: upgrade-insecure-requests
cf-cache-status: HIT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age: 137811
alt-svc: h3=":443"; ma=86400
content-length: 81766
last-modified: Wed, 28 Feb 2024 03:04:51 GMT
server: cloudflare
etag: "13f66-65dea2d3-64a144ca41ea26e;;;"
vary: Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=RKOni%2BY5LjODJQGexuYIY8SJLkXSIvIATUsDP7YW9aHxnpF3X6nP5V%2FqDE%2BpEKdyQQ1%2BysxYwuMDcQWR8b61bgjwJekv%2F5%2B7IRrwdxo0ZWAe5UeGscVWun4KiN4bVtxI6mmBXWsu9sU0v9HAo8w%2Bqg%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: image/jpeg
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
accept-ranges: bytes
platform: hostinger
cf-ray: 863a40fe391c39bc-FRA
expires: Mon, 18 Mar 2024 17:02:16 GMT

GET
H2 200 biopharma_apac_website_banner_300_x_150_px_2_-64.png
biopharmaapac.com/uploads/static/ 17 KB
18 KB 36ms
30ms Image
image/png 2606:4700:3037::6815:6025
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://biopharmaapac.com/uploads/static/biopharma_apac_website_banner_300_x_150_px_2_-64.png

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3037::6815:6025 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

c18a9ffeea428b5c5e073057423716d026d6f0b45780f72d7213a62fc0f9a854

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Wed, 13 Mar 2024 07:19:07 GMT
content-security-policy: upgrade-insecure-requests
cf-cache-status: HIT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age: 137811
alt-svc: h3=":443"; ma=86400
content-length: 17695
last-modified: Fri, 01 Mar 2024 04:57:15 GMT
server: cloudflare
etag: "451f-65e1602b-8299b635f781d3ec;;;"
vary: Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=osJ4laHus1QGq0u0NEJLtYCUIAGZ1793wqRsKBOVk3btQ22EavCqXhRWLbweuPVm9PF9p2DQ8xUjt5YtiSXImiicUYXUkqkW47NlbwTEZPdfbZTfpSwlfpmAbrggp5uNfuji%2BGqrqQGiZmvuBUk%2FnA%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: image/png
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
accept-ranges: bytes
platform: hostinger
cf-ray: 863a40fe392139bc-FRA
expires: Mon, 18 Mar 2024 17:02:16 GMT

GET
H2 200 unnamed-62.gif
biopharmaapac.com/uploads/static/ 36 KB
37 KB 38ms
31ms Image
image/gif 2606:4700:3037::6815:6025
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://biopharmaapac.com/uploads/static/unnamed-62.gif

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3037::6815:6025 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

461c3cb2d353f837be8a4d1b9ed67e8accdce9af1d69fb0819e9c3d593fb06e0

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Wed, 13 Mar 2024 07:19:07 GMT
content-security-policy: upgrade-insecure-requests
cf-cache-status: HIT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age: 137811
alt-svc: h3=":443"; ma=86400
content-length: 37253
last-modified: Thu, 15 Feb 2024 04:36:58 GMT
server: cloudflare
etag: "9185-65cd94ea-254f3b0d30889995;;;"
vary: Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=JgKiGM5SFlXEzae%2BmnpGM5PA0dJ5jMPhU0Gc1Ikno%2BPg1MX6Zh0Aasw1a%2BC1VbBbAtaQjep573AidH3vIoGqdlQ45r42RJfb7pjTIKk%2Fb6I%2BXG8sM5ivCK2DMy3naytTLum5y1U30vKbMpjYQUg3ig%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: image/gif
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
accept-ranges: bytes
platform: hostinger
cf-ray: 863a40fe392339bc-FRA
expires: Mon, 18 Mar 2024 17:02:16 GMT

GET
H2 200 bma_blwa_ctfa_banner_300x250_-63.png
biopharmaapac.com/uploads/static/ 90 KB
91 KB 37ms
31ms Image
image/png 2606:4700:3037::6815:6025
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://biopharmaapac.com/uploads/static/bma_blwa_ctfa_banner_300x250_-63.png

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3037::6815:6025 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

0046d0bccf3c8c651eb13194876e354089107016c46d71c9f5dd07c1987fe703

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Wed, 13 Mar 2024 07:19:07 GMT
content-security-policy: upgrade-insecure-requests
cf-cache-status: HIT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age: 137811
alt-svc: h3=":443"; ma=86400
content-length: 92190
last-modified: Wed, 14 Feb 2024 06:34:11 GMT
server: cloudflare
etag: "1681e-65cc5ee3-cbfc3bdf370f6db6;;;"
vary: Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=xLFfZjAcMEtyPRjsBG1f5Ainz9qw0c0fAAovhbNDFq43rNuHX6vc33qgiKA2HMhO5EVk5ohlZwcpsl3k0HO2SlWZUgvOI0Liu1KR%2BBLufGal0uXwXEK3av6i9rdwpkpom4YF1YoClLkbB7CYDKBItw%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: image/png
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
accept-ranges: bytes
platform: hostinger
cf-ray: 863a40fe392639bc-FRA
expires: Mon, 18 Mar 2024 17:02:16 GMT

GET
H2 200 biopharma_apac_women_s_day_special-4471.jpg
biopharmaapac.com/uploads/articles/ 335 KB
336 KB 49ms
43ms Image
image/jpeg 2606:4700:3037::6815:6025
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://biopharmaapac.com/uploads/articles/biopharma_apac_women_s_day_special-4471.jpg

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3037::6815:6025 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

b66c3c1a78891bb787960a25e94d7e37f7421aa512290ad392d9ba058a0be8eb

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Wed, 13 Mar 2024 07:19:07 GMT
content-security-policy: upgrade-insecure-requests
cf-cache-status: HIT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age: 443635
alt-svc: h3=":443"; ma=86400
content-length: 343420
last-modified: Thu, 07 Mar 2024 13:59:30 GMT
server: cloudflare
etag: "53d7c-65e9c842-afe76bc457a1672a;;;"
vary: Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=5veBnxGa%2FKtIkccuZmi8AB6CnTsQbf44y8qGrGp3bSRLS%2Fv1xeXtkbFn8BoKX6LkEFrqP22rNYpshzy2ys%2Bb3wtlg1%2FnQzRRWdAlGyKxe5sMg6tem8r9NFcW%2FOHERx%2FGE0%2F%2FW%2BSGMCXiTFF8%2Bw85DA%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: image/jpeg
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
accept-ranges: bytes
platform: hostinger
cf-ray: 863a40fe392839bc-FRA
expires: Fri, 15 Mar 2024 04:05:12 GMT

GET
H2 200 screenshot_2023_12_13_at_9_44_52_am_1_-4048.jpg
biopharmaapac.com/uploads/articles/ 288 KB
289 KB 35ms
29ms Image
image/jpeg 2606:4700:3037::6815:6025
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://biopharmaapac.com/uploads/articles/screenshot_2023_12_13_at_9_44_52_am_1_-4048.jpg

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3037::6815:6025 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

83f6a2f6448f30ab61299c0d6e8e20b4b7c017ae7bf88c6bdd1f194dfe2fe167

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Wed, 13 Mar 2024 07:19:07 GMT
content-security-policy: upgrade-insecure-requests
cf-cache-status: HIT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age: 137811
alt-svc: h3=":443"; ma=86400
content-length: 294993
last-modified: Sun, 24 Dec 2023 14:35:36 GMT
server: cloudflare
etag: "48051-658841b8-bb450c1fb5517fd4;;;"
vary: Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=dAOQzLUVOeEi%2Fjf2AflEZ7YYkcSzFjKqvwu%2Bhul%2BnzYGduv%2BcLCbwviWReSAAIvs%2F3B0vbWVtQq9gJbJs3bTH0jocTK2DGpaE6qLS62HntUX3jIIIEHanY%2F9N60IsOLOVFrrkzCVJ8VOIJfqOjrmzg%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: image/jpeg
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
accept-ranges: bytes
platform: hostinger
cf-ray: 863a40fe392a39bc-FRA
expires: Mon, 18 Mar 2024 17:02:16 GMT

GET
H2 200 screenshot_2023_12_12_at_9_45_03_pm-4050.jpg
biopharmaapac.com/uploads/articles/ 288 KB
289 KB 36ms
30ms Image
image/jpeg 2606:4700:3037::6815:6025
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://biopharmaapac.com/uploads/articles/screenshot_2023_12_12_at_9_45_03_pm-4050.jpg

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3037::6815:6025 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

ea7b8eee37df67caed7f2754922f5d8d164823af9301ed1373066f1303ad0ab9

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Wed, 13 Mar 2024 07:19:07 GMT
content-security-policy: upgrade-insecure-requests
cf-cache-status: HIT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age: 100267
alt-svc: h3=":443"; ma=86400
content-length: 294858
last-modified: Sun, 24 Dec 2023 14:35:36 GMT
server: cloudflare
etag: "47fca-658841b8-62d80177a0fe736;;;"
vary: Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=rnXtu%2BtQwnlPFe5Zbz%2Bnf72giuh%2BbLhm4GGzZsoL9JAWkNkPfj4Mew5sK9fjZOH%2FZky41%2BxruPlinBldtMcgbxQw3u%2BBoaoiytjP7CdpWmYMzkU73dCRyRb5LmeruBL36mQrCk8qlO2FsERic7kgkw%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: image/jpeg
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
accept-ranges: bytes
platform: hostinger
cf-ray: 863a40fe392c39bc-FRA
expires: Tue, 19 Mar 2024 03:28:00 GMT

GET
H2 200 BPA-Newsletter.jpg
biopharmaapac.com/bundles/taai/app/site/images/ 94 KB
95 KB 37ms
31ms Image
image/jpeg 2606:4700:3037::6815:6025
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://biopharmaapac.com/bundles/taai/app/site/images/BPA-Newsletter.jpg

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3037::6815:6025 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

4e43e7bdb59b9ba8fc890be3bf4a501b4b50d46f22b3be93b57c40d8052b819b

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Wed, 13 Mar 2024 07:19:07 GMT
content-security-policy: upgrade-insecure-requests
cf-cache-status: HIT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age: 137811
alt-svc: h3=":443"; ma=86400
content-length: 96426
last-modified: Sun, 24 Dec 2023 14:35:33 GMT
server: cloudflare
etag: "178aa-658841b5-3e905d9c404bb97;;;"
vary: Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=xyWmr5D1NHIuggL1trAvCYDvNlf9n8TU%2BrcruDQBiFNbCmR4KXd5Tk1nBz0J0O729U1o5p8txCwwLvZmuOHizNyCZLv%2Fqeod%2BLhSp9nKWTSiOSbuNSvizAPGybVbeOcOOD6yzrkXvnwnpwR2B100eQ%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: image/jpeg
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
accept-ranges: bytes
platform: hostinger
cf-ray: 863a40fe392e39bc-FRA
expires: Mon, 18 Mar 2024 17:02:16 GMT

GET
H2 200 email-decode.min.js Show response
biopharmaapac.com/cdn-cgi/scripts/5c5dd728/cloudflare-static/ 1 KB
1 KB 18ms
10ms Script
application/javascript 2606:4700:3037::6815:6025
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://biopharmaapac.com/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3037::6815:6025 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

2595496fe48df6fcf9b1bc57c29a744c121eb4dd11566466bc13d2e52e6bbcc8

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Frame-Options	DENY

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Wed, 13 Mar 2024 07:19:07 GMT
content-encoding: gzip
x-content-type-options: nosniff
last-modified: Tue, 05 Mar 2024 17:52:43 GMT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
etag: W/"65e75beb-4d7"
vary: Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=KIVib5XVQDPa5TPeMEk%2Fzct8OM5Ss6m%2FGYI5p4TXpY9tH6eaar7eGCxz9ae42X5QAGUASuV%2FMsy4tmoTIqqWqrvv5cl8nrBcNgEy3bSFhv0PV5dNlVQuYoUiHL2ohhV%2Bzh%2BANWcxHCKvIKZjoqFdmA%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: application/javascript
x-frame-options: DENY
cache-control: max-age=172800, public
cf-ray: 863a40fe391139bc-FRA
expires: Fri, 15 Mar 2024 07:19:07 GMT

GET
H2 200 jquery-3.6.0.min.js Show response
biopharmaapac.com/bundles/taai/app/site/js/ 87 KB
32 KB 38ms
30ms Script
application/x-javascript 2606:4700:3037::6815:6025
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://biopharmaapac.com/bundles/taai/app/site/js/jquery-3.6.0.min.js

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3037::6815:6025 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

ff1523fb7389539c84c65aba19260648793bb4f5e29329d2ee8804bc37a3fe6e

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Wed, 13 Mar 2024 07:19:07 GMT
content-security-policy: upgrade-insecure-requests
content-encoding: br
cf-cache-status: HIT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age: 128181
alt-svc: h3=":443"; ma=86400
last-modified: Sun, 24 Dec 2023 14:35:33 GMT
server: cloudflare
etag: W/"15d9d-658841b5-76abcfcbc9734b31;br"
vary: Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=BWdugP%2B%2BvSIWxWAiCrNZI5GWL497qhYEjiE%2FP3ZnoJn7UbXboxHe9mJqxeXt9P2%2BmB4vyWoOPAhIp6%2Bazm1kojO51quBaEWZGk85eeKMz4orvMIksdXz%2BZtjt5GUWTYjyD9R6NNu6pHyL5d%2Buw5shw%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: application/x-javascript
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
platform: hostinger
cf-ray: 863a40fe391339bc-FRA
expires: Mon, 18 Mar 2024 19:42:45 GMT

GET
H2 200 popper.min.js Show response
biopharmaapac.com/bundles/taai/app/site/js/ 21 KB
8 KB 50ms
43ms Script
application/x-javascript 2606:4700:3037::6815:6025
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://biopharmaapac.com/bundles/taai/app/site/js/popper.min.js

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3037::6815:6025 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

c776195ad46333c6c9a9fe3c74502ffea9a02faf122388ea3567922cc65a3060

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Wed, 13 Mar 2024 07:19:07 GMT
content-security-policy: upgrade-insecure-requests
content-encoding: br
cf-cache-status: HIT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age: 128181
alt-svc: h3=":443"; ma=86400
last-modified: Sun, 24 Dec 2023 14:35:33 GMT
server: cloudflare
etag: W/"5309-658841b5-f0a1cf827833c88e;br"
vary: Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=cgU1Z5uDLxnuRI7A0zv2iSbo0Q1S88iV1jNOzoGj1JCuIzB%2BDHlms1wE6RaJMeE7s1XDc7NYqbIT1iqlpZKf12OU3oSn2HXKU6IFMdN7tTrh6o4Vq1YWtGPUgE52XKdNKwuebk9hkGcw90ryMB5ezg%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: application/x-javascript
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
platform: hostinger
cf-ray: 863a40fe391539bc-FRA
expires: Mon, 18 Mar 2024 19:42:46 GMT

GET
H2 200 bootstrap.min.js Show response
biopharmaapac.com/bundles/taai/app/site/js/ 62 KB
16 KB 38ms
31ms Script
application/x-javascript 2606:4700:3037::6815:6025
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://biopharmaapac.com/bundles/taai/app/site/js/bootstrap.min.js

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3037::6815:6025 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

d8968086f7509df34c3278563dab87399da4f9dcdfb419818e3a309eedc70b88

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Wed, 13 Mar 2024 07:19:07 GMT
content-security-policy: upgrade-insecure-requests
content-encoding: br
cf-cache-status: HIT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age: 128181
alt-svc: h3=":443"; ma=86400
last-modified: Sun, 24 Dec 2023 14:35:33 GMT
server: cloudflare
etag: W/"f708-658841b5-af11bc98bc815e7d;br"
vary: Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=sfOHM8%2FxUdoToO4rRXX8%2Foh8cWWoQDhPgfKdVzunlxPyIXJ52lXZM%2BgU0c0ZoNu6b8HcxdMo%2BJEMtCQa5%2BUFly7c3BF1pSSoLpVHYGrEhnDf8oRvEbPnwRAstOJ%2FOfpapsqLjZ5Z63KdCrvnTKWrEA%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: application/x-javascript
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
platform: hostinger
cf-ray: 863a40fe391839bc-FRA
expires: Mon, 18 Mar 2024 19:42:46 GMT

GET
H2 200 jquery.autoscroll.js Show response
biopharmaapac.com/bundles/taai/app/site/js/ 1 KB
993 B 34ms
27ms Script
application/x-javascript 2606:4700:3037::6815:6025
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://biopharmaapac.com/bundles/taai/app/site/js/jquery.autoscroll.js

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:3037::6815:6025 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

c6be6411d784cb509362d794eb35273a24661f430ef0858982cac95fbb23e23d

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Wed, 13 Mar 2024 07:19:07 GMT
content-security-policy: upgrade-insecure-requests
content-encoding: br
cf-cache-status: HIT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age: 432060
alt-svc: h3=":443"; ma=86400
last-modified: Sun, 24 Dec 2023 14:35:33 GMT
server: cloudflare
etag: W/"59b-658841b5-93f15deffd8af24b;br"
vary: Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=nDa6Mq8C6an4c8H9N4RCKeuWfmlJvx0L2VoPwHBv%2B3GESiDKLAR32kM29SmNy4cTkxS4qrgYXWBFEcGVaiKafdFtSYmYfo9P0FVKGXus6k%2BPRwV8FyOGxhZF56EfbpPMMKwYJoouriBmQvHRrvkgdg%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: application/x-javascript
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
platform: hostinger
cf-ray: 863a40fe391939bc-FRA
expires: Fri, 15 Mar 2024 07:18:07 GMT

GET
H2 200 lOcQEjAN7YU Show response
www.youtube.com/embed/ Frame EBDE 89 KB
39 KB 105ms
67ms Document
text/html 2a00:1450:4001:80b::200e
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.youtube.com/embed/lOcQEjAN7YU

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:80b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

ESF /

Resource Hash

ac715d4099aae26055258f42cf33ccb81a8612187c72e5f782804469af514853

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://biopharmaapac.com/
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36
accept-language: de-DE,de;q=0.9

Response headers

accept-ch: Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control: no-cache, no-store, max-age=0, must-revalidate
content-encoding: br
content-type: text/html; charset=utf-8
cross-origin-opener-policy-report-only: same-origin; report-to="youtube_main"
cross-origin-resource-policy: cross-origin
date: Wed, 13 Mar 2024 07:19:07 GMT
expires: Mon, 01 Jan 1990 00:00:00 GMT
origin-trial: AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
p3p: CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
permissions-policy: ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
pragma: no-cache
report-to: {"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
server: ESF
strict-transport-security: max-age=31536000
vary: Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
x-content-type-options: nosniff
x-xss-protection: 0

GET
H3 200 back-web.jpg
biopharmaapac.com/bundles/taai/app/site/images/ 180 KB
180 KB 41ms
40ms Image
image/jpeg 2606:4700:3037::6815:6025
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://biopharmaapac.com/bundles/taai/app/site/images/back-web.jpg

Requested by

Host: biopharmaapac.com
URL: https://biopharmaapac.com/bundles/taai/app/site/css/style.css

Protocol

Security

QUIC, , AES_128_GCM

Server

2606:4700:3037::6815:6025 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

847bedbf9186a36abc8402681b8008ace8c6bd698130bb53317a82cf3e6df40c

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://biopharmaapac.com/bundles/taai/app/site/css/style.css
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Wed, 13 Mar 2024 07:19:07 GMT
content-security-policy: upgrade-insecure-requests
cf-cache-status: HIT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age: 100267
alt-svc: h3=":443"; ma=86400
content-length: 183859
last-modified: Sun, 24 Dec 2023 14:35:33 GMT
server: cloudflare
etag: "2ce33-658841b5-abdd4f5ac6d5f816;;;"
vary: Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=1HYRAVvl%2F%2BgU3mZAQMTwBm1bnZ%2FswJqoqW8g6Nm18p3BqUy29gE%2FXC7h9QaSLXVAGoCtQ%2Fv3nYUa6WtExOhpqvJRb23IbUGKNIjk%2BM3KTLQfMSPutNmO8Hce6h98YW6U77hFeX0Inknsy4Y9HwkH%2BA%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: image/jpeg
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
accept-ranges: bytes
platform: hostinger
cf-ray: 863a40fe7a5537ce-FRA
priority: u=3,i
expires: Tue, 19 Mar 2024 03:28:00 GMT

GET
H3 200 newsletter-back-Banner.jpg
biopharmaapac.com/bundles/taai/app/site/images/ 67 KB
67 KB 31ms
30ms Image
image/jpeg 2606:4700:3037::6815:6025
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://biopharmaapac.com/bundles/taai/app/site/images/newsletter-back-Banner.jpg

Requested by

Host: biopharmaapac.com
URL: https://biopharmaapac.com/bundles/taai/app/site/css/style.css

Protocol

Security

QUIC, , AES_128_GCM

Server

2606:4700:3037::6815:6025 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

703407ec12879bbe9920345dcba6c5ed3a4903e311e4662c3f369bd5092eb5b4

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://biopharmaapac.com/bundles/taai/app/site/css/style.css
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Wed, 13 Mar 2024 07:19:07 GMT
content-security-policy: upgrade-insecure-requests
cf-cache-status: HIT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age: 100267
alt-svc: h3=":443"; ma=86400
content-length: 68242
last-modified: Sun, 24 Dec 2023 14:35:33 GMT
server: cloudflare
etag: "10a92-658841b5-bed4a88d7a8345a0;;;"
vary: Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=11ZWJjalbWIr%2BCbk%2B1De%2BB%2FqudCwS4uaaXz5dC64Lvd6eqZCt75BZ2Vx8onw2Xii46DIAQCZyHgA4LmawuqBrssRLGbgjmzEhhitVeWDX3Bz7IfEGVlHM2FgB%2Bf7lFDdJn5GbyhVFp0K%2FuIhqCSSIQ%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: image/jpeg
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
accept-ranges: bytes
platform: hostinger
cf-ray: 863a40fe7a5737ce-FRA
priority: u=3,i
expires: Tue, 19 Mar 2024 03:28:00 GMT

GET
H3 200 cd-icon-close.svg
biopharmaapac.com/bundles/taai/app/site/images/ 696 B
1010 B 29ms
28ms Image
image/svg+xml 2606:4700:3037::6815:6025
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://biopharmaapac.com/bundles/taai/app/site/images/cd-icon-close.svg

Requested by

Host: biopharmaapac.com
URL: https://biopharmaapac.com/bundles/taai/app/site/css/style.css

Protocol

Security

QUIC, , AES_128_GCM

Server

2606:4700:3037::6815:6025 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

ba3c42c97d16d249855dcfeed7daf64b7a6f56bb45948a5b6409c39bf037da92

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://biopharmaapac.com/bundles/taai/app/site/css/style.css
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Wed, 13 Mar 2024 07:19:07 GMT
content-security-policy: upgrade-insecure-requests
content-encoding: br
cf-cache-status: HIT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age: 100267
alt-svc: h3=":443"; ma=86400
last-modified: Sun, 24 Dec 2023 14:35:33 GMT
server: cloudflare
etag: W/"2b8-658841b5-4ebfd1f75862087e;br"
vary: Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=fhARWNwNQd0FhCVru9WXKib%2FBRdg%2BQvJHtv1NHmBI18t1dBCD0L6hDL26Hxop8yxv0fwRFLy9swqGmmntIo29pMXLc4yAl3OKsu1TQJBxxkvxcRG1A%2BT9uLpJa23tmRKmYTUpe6Ikk0YQkSbyynfCQ%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: image/svg+xml
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
platform: hostinger
cf-ray: 863a40fe7a5837ce-FRA
priority: u=3,i
expires: Tue, 19 Mar 2024 03:28:00 GMT

GET
H3 200 fontawesome-webfont.woff
biopharmaapac.com/bundles/taai/app/site/fonts/ 82 KB
82 KB 316ms
315ms Font
application/font-woff 2606:4700:3037::6815:6025
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://biopharmaapac.com/bundles/taai/app/site/fonts/fontawesome-webfont.woff?v=4.1.0

Requested by

Host: biopharmaapac.com
URL: https://biopharmaapac.com/bundles/taai/app/site/css/font-awesome.min.css

Protocol

Security

QUIC, , AES_128_GCM

Server

2606:4700:3037::6815:6025 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

66db52b456efe7e29cec11fa09421d03cb09e37ed1b567307ec0444fd605ce31

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

Referer: https://biopharmaapac.com/bundles/taai/app/site/css/font-awesome.min.css
Origin: https://biopharmaapac.com
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Wed, 13 Mar 2024 07:19:07 GMT
content-security-policy: upgrade-insecure-requests
content-encoding: br
cf-cache-status: REVALIDATED
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
alt-svc: h3=":443"; ma=86400
last-modified: Sun, 24 Dec 2023 14:35:33 GMT
server: cloudflare
etag: W/"14730-658841b5-d326144e0621bbb4;;;"
vary: Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=ArUzdYIQSBBW4HccPQjpD2GF7Or9N8iThobgcEctvggXLB3ToJRywxzEm70Z1IlYkGAKsq93%2FTwFsTCws7zZExn4GorKNKkhXvgwLUCCTybe9sekZ87Bm67Ux1mtmOv2XyjVf9soHKlDIxZs1HFrqQ%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: application/font-woff
cache-control: max-age=14400
x-turbo-charged-by: LiteSpeed
platform: hostinger
cf-ray: 863a40fe7a5937ce-FRA
priority: u=0,i=?0

GET
H2 200 www-player.css
www.youtube.com/s/player/704f0391/ Frame EBDE 370 KB
47 KB 7ms
6ms Stylesheet
text/css 2a00:1450:4001:80b::200e
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.youtube.com/s/player/704f0391/www-player.css

Requested by

Host: www.youtube.com
URL: https://www.youtube.com/embed/lOcQEjAN7YU

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:80b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

f8e5652e2e352cf03a24ae72ef43118cf6fdc65047dc8438b19768e0cafb297f

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.youtube.com/embed/lOcQEjAN7YU
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Tue, 12 Mar 2024 21:23:52 GMT
content-encoding: br
x-content-type-options: nosniff
age: 35715
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 47944
x-xss-protection: 0
last-modified: Mon, 11 Mar 2024 04:21:44 GMT
server: sffe
vary: Accept-Encoding, Origin
report-to: {"group":"youtube","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube"}]}
content-type: text/css
cache-control: public, max-age=31536000
accept-ranges: bytes
cross-origin-opener-policy-report-only: same-origin; report-to="youtube"
expires: Wed, 12 Mar 2025 21:23:52 GMT

GET
H2 200 KFOmCnqEu92Fr1Mu4mxK.woff2
fonts.gstatic.com/s/roboto/v18/ Frame EBDE 15 KB
16 KB 31ms
8ms Font
font/woff2 2a00:1450:4001:80b::2003
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://fonts.gstatic.com/s/roboto/v18/KFOmCnqEu92Fr1Mu4mxK.woff2

Requested by

Host: www.youtube.com
URL: https://www.youtube.com/embed/lOcQEjAN7YU

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:80b::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

3e253b66056519aa065b00a453bac37ac5ed8f3e6fe7b542e93a9dcdcc11d0bc

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.youtube.com/
Origin: https://www.youtube.com
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Mon, 11 Mar 2024 21:26:23 GMT
x-content-type-options: nosniff
age: 121964
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 15344
x-xss-protection: 0
last-modified: Mon, 16 Oct 2017 17:32:55 GMT
server: sffe
cross-origin-opener-policy: same-origin; report-to="apps-themes"
report-to: {"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type: font/woff2
access-control-allow-origin: *
cache-control: public, max-age=31536000
accept-ranges: bytes
timing-allow-origin: *
expires: Tue, 11 Mar 2025 21:26:23 GMT

GET
H2 200 KFOlCnqEu92Fr1MmEU9fBBc4.woff2
fonts.gstatic.com/s/roboto/v18/ Frame EBDE 15 KB
15 KB 34ms
12ms Font
font/woff2 2a00:1450:4001:80b::2003
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://fonts.gstatic.com/s/roboto/v18/KFOlCnqEu92Fr1MmEU9fBBc4.woff2

Requested by

Host: www.youtube.com
URL: https://www.youtube.com/embed/lOcQEjAN7YU

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:80b::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

5a8c1e7681318caa29e9f44e8a6e271f6a4067a2703e9916dfd4fe9099241db7

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.youtube.com/
Origin: https://www.youtube.com
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Tue, 12 Mar 2024 09:11:37 GMT
x-content-type-options: nosniff
age: 79650
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 15552
x-xss-protection: 0
last-modified: Mon, 16 Oct 2017 17:33:02 GMT
server: sffe
cross-origin-opener-policy: same-origin; report-to="apps-themes"
report-to: {"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type: font/woff2
access-control-allow-origin: *
cache-control: public, max-age=31536000
accept-ranges: bytes
timing-allow-origin: *
expires: Wed, 12 Mar 2025 09:11:37 GMT

GET
H2 200 embed.js Show response
www.youtube.com/s/player/704f0391/player_ias.vflset/de_DE/ Frame EBDE 57 KB
18 KB 7ms
6ms Script
text/javascript 2a00:1450:4001:80b::200e
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.youtube.com/s/player/704f0391/player_ias.vflset/de_DE/embed.js

Requested by

Host: www.youtube.com
URL: https://www.youtube.com/embed/lOcQEjAN7YU

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:80b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

124fdecbfa9b9b8af618f1b02a392de88b9f6d8e3cbf13a0aa28cd837521390c

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.youtube.com/embed/lOcQEjAN7YU
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Mon, 11 Mar 2024 07:20:29 GMT
content-encoding: br
x-content-type-options: nosniff
age: 172718
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 18071
x-xss-protection: 0
last-modified: Mon, 11 Mar 2024 04:21:44 GMT
server: sffe
vary: Accept-Encoding, Origin
report-to: {"group":"youtube","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube"}]}
content-type: text/javascript
cache-control: public, max-age=31536000
accept-ranges: bytes
cross-origin-opener-policy-report-only: same-origin; report-to="youtube"
expires: Tue, 11 Mar 2025 07:20:29 GMT

GET
H2 200 www-embed-player.js Show response
www.youtube.com/s/player/704f0391/www-embed-player.vflset/ Frame EBDE 319 KB
95 KB 9ms
8ms Script
text/javascript 2a00:1450:4001:80b::200e
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.youtube.com/s/player/704f0391/www-embed-player.vflset/www-embed-player.js

Requested by

Host: www.youtube.com
URL: https://www.youtube.com/embed/lOcQEjAN7YU

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:80b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

edd9c924156589464a6d67d8255a3c8dfa1b3aa63ae938daab172f5dfd35735c

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.youtube.com/embed/lOcQEjAN7YU
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Wed, 13 Mar 2024 05:02:16 GMT
content-encoding: br
x-content-type-options: nosniff
age: 8211
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 97434
x-xss-protection: 0
last-modified: Mon, 11 Mar 2024 04:21:44 GMT
server: sffe
vary: Accept-Encoding, Origin
report-to: {"group":"youtube","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube"}]}
content-type: text/javascript
cache-control: public, max-age=31536000
accept-ranges: bytes
cross-origin-opener-policy-report-only: same-origin; report-to="youtube"
expires: Thu, 13 Mar 2025 05:02:16 GMT

GET
H2 200 base.js Show response
www.youtube.com/s/player/704f0391/player_ias.vflset/de_DE/ Frame EBDE 2 MB
781 KB 9ms
9ms Script
text/javascript 2a00:1450:4001:80b::200e
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.youtube.com/s/player/704f0391/player_ias.vflset/de_DE/base.js

Requested by

Host: www.youtube.com
URL: https://www.youtube.com/embed/lOcQEjAN7YU

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:80b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

b4ee493d8299deb392ae6f809a4a981634ad5db111a0cd10bc745d6620186048

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.youtube.com/embed/lOcQEjAN7YU
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Mon, 11 Mar 2024 07:20:29 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 172718
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 799328
x-xss-protection: 0
last-modified: Mon, 11 Mar 2024 04:21:44 GMT
server: sffe
vary: Accept-Encoding, Origin
report-to: {"group":"youtube","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube"}]}
content-type: text/javascript
cache-control: public, max-age=31536000
accept-ranges: bytes
cross-origin-opener-policy-report-only: same-origin; report-to="youtube"
expires: Tue, 11 Mar 2025 07:20:29 GMT

GET
H3 200 script.js Show response
biopharmaapac.com/bundles/taai/app/site/js/ 8 KB
3 KB 18ms
16ms Script
application/x-javascript 2606:4700:3037::6815:6025
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://biopharmaapac.com/bundles/taai/app/site/js/script.js

Requested by

Protocol

Security

QUIC, , AES_128_GCM

Server

2606:4700:3037::6815:6025 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

6ac1a1a6d852a4b597abee6351f122b5363f1c3f153df5a2b60336bbbe61069d

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Wed, 13 Mar 2024 07:19:07 GMT
content-security-policy: upgrade-insecure-requests
content-encoding: br
cf-cache-status: HIT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age: 128181
alt-svc: h3=":443"; ma=86400
last-modified: Sun, 24 Dec 2023 14:35:33 GMT
server: cloudflare
etag: W/"1ed5-658841b5-3be2fb36bd88fc41;br"
vary: Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=l6tOjkvm9OkVIF6Hy%2F9Pm%2BpiA6nw%2BYoi6xJOKDEu%2BbYu2nBjHLXjT0baBUcYOJF99FNZuCG62venvzPaLFyJw1Z7ccM1Z2DI%2BFSCmE7rkRl4vEfKmDlYbvc7i14md7FbvKWfYnb1tXXeJWWYu1kFKA%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: application/x-javascript
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
platform: hostinger
cf-ray: 863a40ff2b1137ce-FRA
priority: u=1,i=?0
expires: Mon, 18 Mar 2024 19:42:46 GMT

GET
H3 200 dips-site-common.js Show response
biopharmaapac.com/bundles/taai/app/site/js/ 5 KB
2 KB 22ms
20ms Script
application/x-javascript 2606:4700:3037::6815:6025
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://biopharmaapac.com/bundles/taai/app/site/js/dips-site-common.js

Requested by

Protocol

Security

QUIC, , AES_128_GCM

Server

2606:4700:3037::6815:6025 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

b316099d3d0439715256c4bf9b8b59f2323a0af63e65b33e668a1eb3972f2893

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Wed, 13 Mar 2024 07:19:07 GMT
content-security-policy: upgrade-insecure-requests
content-encoding: br
cf-cache-status: HIT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age: 128181
alt-svc: h3=":443"; ma=86400
last-modified: Sun, 24 Dec 2023 14:35:33 GMT
server: cloudflare
etag: W/"13f4-658841b5-e31a95c6373499c0;br"
vary: Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=w2BSQu27ABzRNBtOip0QUl7dw2iYKJDiS0ULySiqnLOqC1LdsQbO%2BGRoF%2BU%2BJeZ1FYdgr4XLy3H%2FGqEoUsltMXHauBPp2Xa4QK72JYjtNWfZDAfxAg882cI2yrg6%2F0H%2BPF8CfdtPN2oHRsD3arCecw%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: application/x-javascript
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
platform: hostinger
cf-ray: 863a40ff2b1237ce-FRA
priority: u=2,i=?0
expires: Mon, 18 Mar 2024 19:42:46 GMT

GET
H2 200 api.js Show response
www.google.com/recaptcha/ 1 KB
1 KB 39ms
16ms Script
text/javascript 2a00:1450:4001:80b::2004
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.google.com/recaptcha/api.js

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:80b::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

GSE /

Resource Hash

3252500be7b91b993ef2af4039c11871773ea1dbda57868f3dbfcd388eb2a66d

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self'
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://biopharmaapac.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Wed, 13 Mar 2024 07:19:07 GMT
content-encoding: gzip
x-content-type-options: nosniff
content-security-policy: frame-ancestors 'self'
server: GSE
x-frame-options: SAMEORIGIN
content-type: text/javascript; charset=utf-8
cache-control: private, max-age=300
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection: 1; mode=block
expires: Wed, 13 Mar 2024 07:19:07 GMT

GET
H2 200 widgets.js Show response
platform.twitter.com/ 91 KB
27 KB 28ms
7ms Script
application/javascript 199.232.188.157
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://platform.twitter.com/widgets.js
Requested by: Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 199.232.188.157 Munich, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software: /
Resource Hash: 173460e89e6a7244218badae2016f65c48a3eae9d400802273eeca18b07336f1

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://biopharmaapac.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Wed, 13 Mar 2024 07:19:07 GMT
content-encoding: gzip
x-amz-server-side-encryption: AES256
x-cache: HIT, HIT
p3p: CP="CAO DSP LAW CURa ADMa DEVa TAIa PSAa PSDa IVAa IVDa OUR BUS IND UNI COM NAV INT"
content-length: 27597
x-served-by: cache-iad-kjyo7100044-IAD, cache-muc13959-MUC
last-modified: Mon, 11 Dec 2023 17:20:28 GMT
etag: "824beb891744db98ccbd3a456e59e0f7+gzip"
vary: Accept-Encoding
access-control-allow-methods: GET
content-type: application/javascript; charset=utf-8
access-control-allow-origin: *
cache-control: public, max-age=1800
accept-ranges: bytes
tw-cdn: FT

GET
H3 200 articulate.min.js Show response
biopharmaapac.com/bundles/taai/assets/global/plugins/text-to-speech/ 8 KB
3 KB 23ms
22ms Script
application/x-javascript 2606:4700:3037::6815:6025
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://biopharmaapac.com/bundles/taai/assets/global/plugins/text-to-speech/articulate.min.js

Requested by

Protocol

Security

QUIC, , AES_128_GCM

Server

2606:4700:3037::6815:6025 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

a8a2031f7cb98a60f55670a991ce71d4b61aaf051a4bf4eaccb2620b218516ec

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Wed, 13 Mar 2024 07:19:07 GMT
content-security-policy: upgrade-insecure-requests
content-encoding: br
cf-cache-status: HIT
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
age: 100267
alt-svc: h3=":443"; ma=86400
last-modified: Sun, 24 Dec 2023 14:35:33 GMT
server: cloudflare
etag: W/"1e7c-658841b5-526d778e2c41316a;br"
vary: Accept-Encoding
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=yzp6aE8edpLb0ghcH%2FhFEqmyEs8D7XpjeR71QMDh1gTvKcxyayNE%2BbTmVhe4jcfuw3KcBuIdkBDRXN4OrnsJ15SIbCVIW9Lrf3sQDv4idxjzUCgpub0amRNhLEER0BuL6JsMCiSe341oSdTNaq2R4Q%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type: application/x-javascript
cache-control: public, max-age=604800
x-turbo-charged-by: LiteSpeed
platform: hostinger
cf-ray: 863a40ff2b1537ce-FRA
priority: u=2,i=?0
expires: Tue, 19 Mar 2024 03:28:00 GMT

GET
H2 200 js Show response
www.googletagmanager.com/gtag/ 266 KB
91 KB 41ms
17ms Script
application/javascript 2a00:1450:4001:80e::2008
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.googletagmanager.com/gtag/js?id=G-2E2BXNMKP4

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:80e::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

Google Tag Manager /

Resource Hash

072a8a915f0c9422d59f5f551fa61929c57358c6b9627d75f3fca7b19a5b88ce

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://biopharmaapac.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Wed, 13 Mar 2024 07:19:07 GMT
content-encoding: br
strict-transport-security: max-age=31536000; includeSubDomains
server: Google Tag Manager
vary: Accept-Encoding
content-type: application/javascript; charset=UTF-8
access-control-allow-origin: *
cache-control: private, max-age=900
access-control-allow-credentials: true
cross-origin-resource-policy: cross-origin
access-control-allow-headers: Cache-Control
content-length: 92933
x-xss-protection: 0
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
expires: Wed, 13 Mar 2024 07:19:07 GMT

GET
H2 200 v84a3a4012de94ce1a686ba8c167c359c1696973893317 Show response
static.cloudflareinsights.com/beacon.min.js/ 20 KB
7 KB 66ms
46ms Script
text/javascript 2606:4700::6810:5049
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL: https://static.cloudflareinsights.com/beacon.min.js/v84a3a4012de94ce1a686ba8c167c359c1696973893317
Requested by: Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700::6810:5049 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6153d13804862b0fc1c016cf1129f34cb7c6185f2cf4bf1a3a862eecdab50101

Request headers

Referer: https://biopharmaapac.com/
Origin: https://biopharmaapac.com
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Wed, 13 Mar 2024 07:19:07 GMT
content-encoding: gzip
last-modified: Tue, 10 Oct 2023 21:38:13 GMT
server: cloudflare
etag: W/"2023.10.0"
vary: Accept-Encoding
content-type: text/javascript;charset=UTF-8
access-control-allow-origin: *
cache-control: public, max-age=86400
cross-origin-resource-policy: cross-origin
cf-ray: 863a40ff49849bbf-FRA

GET
H2 200 recaptcha__de.js Show response
www.gstatic.com/recaptcha/releases/QquE1_MNjnFHgZF4HPsEcf_2/ 494 KB
197 KB 28ms
7ms Script
text/javascript 2a00:1450:4001:81c::2003
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.gstatic.com/recaptcha/releases/QquE1_MNjnFHgZF4HPsEcf_2/recaptcha__de.js

Requested by

Host: www.google.com
URL: https://www.google.com/recaptcha/api.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:81c::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

5564f45c0991c7cceb19c0fb637ee44b119fb14c6cbf3691540a9cad11e1edf3

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://biopharmaapac.com/
Origin: https://biopharmaapac.com
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Tue, 12 Mar 2024 22:31:32 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 31655
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/recaptcha
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 200579
x-xss-protection: 0
last-modified: Mon, 04 Mar 2024 05:02:47 GMT
server: sffe
cross-origin-opener-policy: same-origin-allow-popups; report-to="recaptcha"
vary: Accept-Encoding
report-to: {"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type: text/javascript
access-control-allow-origin: *
cache-control: public, max-age=31536000
accept-ranges: bytes
expires: Wed, 12 Mar 2025 22:31:32 GMT

GET
H2

200

id Show response
googleads.g.doubleclick.net/pagead/ Frame EBDE
Redirect Chain

https://googleads.g.doubleclick.net/pagead/id
https://googleads.g.doubleclick.net/pagead/id?slf_rd=1

100 B
242 B

15ms
14ms

XHR
application/json

2a00:1450:4001:829::2002
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://googleads.g.doubleclick.net/pagead/id?slf_rd=1

Requested by

Host: www.youtube.com
URL: https://www.youtube.com/embed/lOcQEjAN7YU

Protocol

Server

2a00:1450:4001:829::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

cafe /

Resource Hash

c93ec9f7864a39fb7552a9f6761f132da2849e14e3c45848c35f3629797cff62

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.youtube.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Wed, 13 Mar 2024 07:19:07 GMT
content-encoding: gzip
x-content-type-options: nosniff
p3p: policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy: cross-origin
content-disposition: attachment; filename="f.txt"
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 120
x-xss-protection: 0
pragma: no-cache
server: cafe
content-type: application/json; charset=UTF-8
access-control-allow-origin: https://www.youtube.com
cache-control: no-cache, no-store, must-revalidate
access-control-allow-credentials: true
timing-allow-origin: *
expires: Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

date: Wed, 13 Mar 2024 07:19:07 GMT
x-content-type-options: nosniff
p3p: policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 0
x-xss-protection: 0
pragma: no-cache
server: cafe
content-type: text/html; charset=UTF-8
location: https://googleads.g.doubleclick.net/pagead/id?slf_rd=1
access-control-allow-origin: https://www.youtube.com
cache-control: no-cache, no-store, must-revalidate
access-control-allow-credentials: true
timing-allow-origin: *
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2 200 ad_status.js Show response
static.doubleclick.net/instream/ Frame EBDE 29 B
495 B 46ms
7ms Script
text/javascript 2a00:1450:4001:828::2006
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://static.doubleclick.net/instream/ad_status.js

Requested by

Host: www.youtube.com
URL: https://www.youtube.com/s/player/704f0391/www-embed-player.vflset/www-embed-player.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:828::2006 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

eed0dc1fdb5d97ed188ae16fd5e1024a5bb744af47340346be2146300a6c54b9

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.youtube.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Wed, 13 Mar 2024 07:07:39 GMT
x-content-type-options: nosniff
age: 688
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 29
x-xss-protection: 0
last-modified: Thu, 12 Dec 2013 23:40:16 GMT
server: sffe
report-to: {"group":"ads-doubleclick-media","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-doubleclick-media"}]}
content-type: text/javascript
access-control-allow-origin: *
cache-control: public, max-age=900
accept-ranges: bytes
timing-allow-origin: *
cross-origin-opener-policy-report-only: same-origin; report-to="ads-doubleclick-media"
expires: Wed, 13 Mar 2024 07:22:39 GMT

GET
H2 200 widget_iframe.2f70fb173b9000da126c79afe2098f02.html Show response
platform.twitter.com/widgets/ Frame 18CF 319 KB
103 KB 8ms
8ms Document
text/html 199.232.188.157
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://platform.twitter.com/widgets/widget_iframe.2f70fb173b9000da126c79afe2098f02.html?origin=https%3A%2F%2Fbiopharmaapac.com
Requested by: Host: platform.twitter.com
URL: https://platform.twitter.com/widgets.js
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 199.232.188.157 Munich, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software: /
Resource Hash: 70c00445d6632039ed99af760731daf3bf60eb12061863ee61e2cd7276a54d18

Request headers

Referer: https://biopharmaapac.com/
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36
accept-language: de-DE,de;q=0.9

Response headers

accept-ranges: bytes
access-control-allow-methods: GET
access-control-allow-origin: *
cache-control: public, max-age=315360000
content-encoding: gzip
content-length: 105429
content-type: text/html; charset=utf-8
date: Wed, 13 Mar 2024 07:19:07 GMT
etag: "81267302efdfb3e4524a22631a8fc99e+gzip"
last-modified: Mon, 11 Dec 2023 17:19:49 GMT
p3p: CP="CAO DSP LAW CURa ADMa DEVa TAIa PSAa PSDa IVAa IVDa OUR BUS IND UNI COM NAV INT"
tw-cdn: FT
vary: Accept-Encoding
x-amz-server-side-encryption: AES256
x-cache: HIT, HIT
x-served-by: cache-iad-kjyo7100176-IAD, cache-muc13959-MUC

OPTIONS
H2 200 Create
jnn-pa.googleapis.com/$rpc/google.internal.waa.v1.Waa/ Frame 0
0 37ms
15ms Preflight
text/html 2a00:1450:4001:802::200a
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://jnn-pa.googleapis.com/$rpc/google.internal.waa.v1.Waa/Create

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:802::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

ESF /

Resource Hash

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	0

Request headers

Accept: */*
Access-Control-Request-Headers: content-type,x-goog-api-key,x-user-agent
Access-Control-Request-Method: POST
Origin: https://www.youtube.com
Sec-Fetch-Mode: cors
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

access-control-allow-credentials: true
access-control-allow-headers: content-type,x-goog-api-key,x-user-agent
access-control-allow-methods: DELETE,GET,HEAD,OPTIONS,PATCH,POST,PUT
access-control-allow-origin: https://www.youtube.com
access-control-max-age: 3600
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 0
content-type: text/html
date: Wed, 13 Mar 2024 07:19:07 GMT
server: ESF
vary: origin referer x-origin
x-content-type-options: nosniff
x-frame-options: SAMEORIGIN
x-xss-protection: 0

POST
H2 200 Create Show response
jnn-pa.googleapis.com/$rpc/google.internal.waa.v1.Waa/ Frame EBDE 88 KB
41 KB 24ms
23ms XHR
application/json+protobuf 2a00:1450:4001:802::200a
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://jnn-pa.googleapis.com/$rpc/google.internal.waa.v1.Waa/Create

Requested by

Host: www.youtube.com
URL: https://www.youtube.com/s/player/704f0391/player_ias.vflset/de_DE/base.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:802::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

ESF /

Resource Hash

1009b5daf53551e6512fdf249cc687982976f83185d306c8181843d0f7580037

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	0

Request headers

X-User-Agent: grpc-web-javascript/0.1
Referer: https://www.youtube.com/
X-Goog-Api-Key: AIzaSyDyT5W0Jh49F30Pqqtyfdf7pDLFKLJoAnw
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36
Content-Type: application/json+protobuf

Response headers

date: Wed, 13 Mar 2024 07:19:07 GMT
content-encoding: gzip
x-content-type-options: nosniff
server: ESF
vary: Origin, X-Origin, Referer
x-frame-options: SAMEORIGIN
content-type: application/json+protobuf; charset=UTF-8
access-control-allow-origin: https://www.youtube.com
access-control-expose-headers: vary,vary,vary,content-encoding,date,server,content-length
cache-control: private
access-control-allow-credentials: true
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 41451
x-xss-protection: 0

GET
H3 200 remote.js Show response
www.youtube.com/s/player/704f0391/player_ias.vflset/de_DE/ Frame EBDE 118 KB
33 KB 7ms
7ms Script
text/javascript 2a00:1450:4001:80b::200e
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.youtube.com/s/player/704f0391/player_ias.vflset/de_DE/remote.js

Requested by

Host: www.youtube.com
URL: https://www.youtube.com/s/player/704f0391/player_ias.vflset/de_DE/base.js

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:80b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

6f123a87b6a0d2b7dd3fbf96b12a147dd96eeb0101e7a15279d109bb00c0b458

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.youtube.com/embed/lOcQEjAN7YU
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Mon, 11 Mar 2024 07:24:51 GMT
content-encoding: br
x-content-type-options: nosniff
age: 172456
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 34000
x-xss-protection: 0
last-modified: Mon, 11 Mar 2024 04:21:44 GMT
server: sffe
vary: Accept-Encoding, Origin
report-to: {"group":"youtube","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube"}]}
content-type: text/javascript
cache-control: public, max-age=31536000
accept-ranges: bytes
cross-origin-opener-policy-report-only: same-origin; report-to="youtube"
expires: Tue, 11 Mar 2025 07:24:51 GMT

GET
H2 200 cFnio4gi1vh2CYU0Ett6xA0G_Vyd_QBYpQEc_-VJhJY.js Show response
www.google.com/js/th/ Frame EBDE 51 KB
20 KB 8ms
7ms Script
text/javascript 2a00:1450:4001:80b::2004
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.google.com/js/th/cFnio4gi1vh2CYU0Ett6xA0G_Vyd_QBYpQEc_-VJhJY.js

Requested by

Host: www.youtube.com
URL: https://www.youtube.com/s/player/704f0391/player_ias.vflset/de_DE/base.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:80b::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

7059e2a38822d6f87609853412db7ac40d06fd5c9dfd0058a5011cffe5498496

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.youtube.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Wed, 13 Mar 2024 06:10:30 GMT
content-encoding: br
x-content-type-options: nosniff
age: 4117
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/botguard-scs
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 20294
x-xss-protection: 0
last-modified: Mon, 04 Mar 2024 15:30:00 GMT
server: sffe
cross-origin-opener-policy: same-origin; report-to="botguard-scs"
vary: Accept-Encoding
report-to: {"group":"botguard-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/botguard-scs"}]}
content-type: text/javascript
cache-control: public, max-age=31536000
accept-ranges: bytes
expires: Thu, 13 Mar 2025 06:10:30 GMT

GET
H2 200 sddefault.jpg
i.ytimg.com/vi/lOcQEjAN7YU/ Frame EBDE 56 KB
56 KB 43ms
8ms Image
image/jpeg 2a00:1450:4001:82a::2016
GOOGLE

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://i.ytimg.com/vi/lOcQEjAN7YU/sddefault.jpg

Requested by

Host: www.youtube.com
URL: https://www.youtube.com/embed/lOcQEjAN7YU

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:82a::2016 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

c6249825bf65aff6ca67dc59c7b1a8ba7442d6e5402ccf3037555fac6d3eacd5

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.youtube.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Wed, 13 Mar 2024 05:51:19 GMT
x-content-type-options: nosniff
age: 5268
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 57397
x-xss-protection: 0
server: sffe
etag: "1697658673"
vary: Origin
report-to: {"group":"youtube","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube"}]}
content-type: image/jpeg
cache-control: public, max-age=7200
accept-ranges: bytes
timing-allow-origin: *
cross-origin-opener-policy-report-only: same-origin; report-to="youtube"
expires: Wed, 13 Mar 2024 07:51:19 GMT

POST
H2 204 collect
region1.google-analytics.com/g/ 0
255 B 35ms
14ms Ping
text/plain 2001:4860:4802:32::36
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL: https://region1.google-analytics.com/g/collect?v=2&tid=G-2E2BXNMKP4&gtm=45je43b0v877295126za200&_p=1710314347423&gcd=13l3l3l2l1&npa=1&dma_cps=sypham&dma=1&cid=270205643.1710314348&ul=en-us&sr=1600x1200&uaa=&uab=&uafvl=&uamb=0&uam=&uap=&uapv=&uaw=0&pscdl=noapi&_s=1&sid=1710314347&sct=1&seg=0&dl=https%3A%2F%2Fbiopharmaapac.com%2Fnews%2F134%2F4445%2Fcarsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html%3F__s%3D5slvqff6wv2m7m6e2l9i%26utm_source%3Ddrip%26utm_medium%3Demail%26utm_campaign%3DInnovating%2Bfor%2BHealth%2BEquity%253A%2BTakeda%2527s%2BBlueprint%2Bfor%2BMedicine%2BAccess%2Bin%2BAPAC%2Bwith%2BDion%2BWarren&dt=CARsgen%20Therapeutics%20Receives%20NMPA%20Approval%20for%20Breakthrough%20Multiple%20Myeloma%20CAR%20T-Cell%20Therapy&en=page_view&_fv=1&_nsi=1&_ss=1&_ee=1&tfd=1563
Requested by: Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=G-2E2BXNMKP4
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2001:4860:4802:32::36 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software: Golfe2 /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://biopharmaapac.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

pragma: no-cache
date: Wed, 13 Mar 2024 07:19:07 GMT
server: Golfe2
content-type: text/plain
access-control-allow-origin: https://biopharmaapac.com
cache-control: no-cache, no-store, must-revalidate
access-control-allow-credentials: true
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
DATA 200
OK truncated
/ Frame EBDE 175 B
0 Image
image/png

General

Check archive.org

Show headers Download Go to Show image

Full URL: data:truncated
Protocol: DATA
Server: -, , ASN (),
Reverse DNS
Software: /
Resource Hash: 67ea46bc3d15351067faccb3613bd833dd3f15137a4b4a09f2e873fd41d024d2

Request headers

accept-language: de-DE,de;q=0.9
Referer
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

Content-Type: image/png

GET
H2 200 AIdro_mF941GFO9OenvSfhjHJ0Rla0vgxlIRLHhZnwny6A=s68-c-k-c0x00ffffff-no-rj
yt3.ggpht.com/ytc/ Frame EBDE 2 KB
2 KB 42ms
6ms Image
image/jpeg 2a00:1450:4001:811::2001
GOOGLE

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://yt3.ggpht.com/ytc/AIdro_mF941GFO9OenvSfhjHJ0Rla0vgxlIRLHhZnwny6A=s68-c-k-c0x00ffffff-no-rj

Requested by

Host: www.youtube.com
URL: https://www.youtube.com/embed/lOcQEjAN7YU

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:811::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

fife /

Resource Hash

ad2bc225f3195fea2b8a31567f3afd31efad10e5b3785a91b432e874c8a5a83f

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.youtube.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Wed, 13 Mar 2024 06:45:15 GMT
x-content-type-options: nosniff
age: 2032
content-disposition: inline;filename="unnamed.jpg"
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 1961
x-xss-protection: 0
server: fife
etag: "vd6"
vary: Origin
content-type: image/jpeg
access-control-allow-origin: *
access-control-expose-headers: Content-Length
cache-control: public, max-age=86400, no-transform
timing-allow-origin: *
expires: Thu, 14 Mar 2024 06:45:15 GMT

GET
H2 200 settings Show response
syndication.twitter.com/ Frame 18CF 869 B
659 B 132ms
111ms Fetch
application/json 104.244.42.8
TWITTER

General

Check archive.org

Show headers Download Go to

Full URL

https://syndication.twitter.com/settings?session_id=ef1bf44aec75c6dbadc10b678fe302aaf72a29ee

Requested by

Host: platform.twitter.com
URL: https://platform.twitter.com/widgets/widget_iframe.2f70fb173b9000da126c79afe2098f02.html?origin=https%3A%2F%2Fbiopharmaapac.com

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

104.244.42.8 , United States, ASN13414 (TWITTER, US),

Reverse DNS

Software

tsa_o /

Resource Hash

302da628a6afc3e93f1b86bf7c65e4d6536d8283d78266964822a76d1c645aa4

Security Headers

Name	Value
Strict-Transport-Security	max-age=631138519

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://platform.twitter.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

x-response-time: 104
date: Wed, 13 Mar 2024 07:19:07 GMT
content-encoding: gzip
strict-transport-security: max-age=631138519
last-modified: Wed, 13 Mar 2024 07:19:07 GMT
server: tsa_o
vary: Origin
content-type: application/json; charset=utf-8
access-control-allow-origin: https://platform.twitter.com
x-transaction-id: 476f0691e05362d7
cache-control: must-revalidate, max-age=600
access-control-allow-credentials: true
perf: 7469935968
x-connection-hash: 32db7f1855aa1ac66fac7bbf89a78cf007dab6cdd34405a57af55e4fabe36a0b
content-length: 337

GET
H3 200 anchor Show response
www.google.com/recaptcha/api2/ Frame A6A7 46 KB
29 KB 31ms
30ms Document
text/html 2a00:1450:4001:80b::2004
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC&co=aHR0cHM6Ly9iaW9waGFybWFhcGFjLmNvbTo0NDM.&hl=de&v=QquE1_MNjnFHgZF4HPsEcf_2&size=normal&cb=ez6p3ml2ljab

Requested by

Host: www.gstatic.com
URL: https://www.gstatic.com/recaptcha/releases/QquE1_MNjnFHgZF4HPsEcf_2/recaptcha__de.js

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:80b::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

GSE /

Resource Hash

cd62f110b7b51dd2c7dcd5d7fa601a930924c91b709bb021f59e15eabb3c4a17

Security Headers

Name	Value
Content-Security-Policy	script-src 'report-sample' 'nonce-RTZAdTCf2UaSx_m3b4mq_g' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
X-Content-Type-Options	nosniff
X-Xss-Protection	1; mode=block

Request headers

Referer: https://biopharmaapac.com/
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36
accept-language: de-DE,de;q=0.9

Response headers

alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control: no-cache, no-store, max-age=0, must-revalidate
content-encoding: gzip
content-security-policy: script-src 'report-sample' 'nonce-RTZAdTCf2UaSx_m3b4mq_g' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
content-type: text/html; charset=utf-8
cross-origin-embedder-policy: require-corp
cross-origin-resource-policy: cross-origin
date: Wed, 13 Mar 2024 07:19:07 GMT
expires: Mon, 01 Jan 1990 00:00:00 GMT
pragma: no-cache
report-to: {"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
server: GSE
x-content-type-options: nosniff
x-xss-protection: 1; mode=block

GET
H3 200 anchor Show response
www.google.com/recaptcha/api2/ Frame C2CD 46 KB
29 KB 32ms
32ms Document
text/html 2a00:1450:4001:80b::2004
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC&co=aHR0cHM6Ly9iaW9waGFybWFhcGFjLmNvbTo0NDM.&hl=de&v=QquE1_MNjnFHgZF4HPsEcf_2&size=normal&cb=f20xznm3iu4s

Requested by

Host: www.gstatic.com
URL: https://www.gstatic.com/recaptcha/releases/QquE1_MNjnFHgZF4HPsEcf_2/recaptcha__de.js

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:80b::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

GSE /

Resource Hash

fb23675ecaf990d8b42e85631a063de4ff331217c480a2ffa2a2c7bd55c08adf

Security Headers

Name	Value
Content-Security-Policy	script-src 'report-sample' 'nonce-QBnZtthgUm7K3a82aB-YWg' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
X-Content-Type-Options	nosniff
X-Xss-Protection	1; mode=block

Request headers

Referer: https://biopharmaapac.com/
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36
accept-language: de-DE,de;q=0.9

Response headers

alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control: no-cache, no-store, max-age=0, must-revalidate
content-encoding: gzip
content-security-policy: script-src 'report-sample' 'nonce-QBnZtthgUm7K3a82aB-YWg' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
content-type: text/html; charset=utf-8
cross-origin-embedder-policy: require-corp
cross-origin-resource-policy: cross-origin
date: Wed, 13 Mar 2024 07:19:07 GMT
expires: Mon, 01 Jan 1990 00:00:00 GMT
pragma: no-cache
report-to: {"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
server: GSE
x-content-type-options: nosniff
x-xss-protection: 1; mode=block

OPTIONS
H3 200 GenerateIT
jnn-pa.googleapis.com/$rpc/google.internal.waa.v1.Waa/ Frame 0
0 15ms
15ms Preflight
text/html 2a00:1450:4001:802::200a
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://jnn-pa.googleapis.com/$rpc/google.internal.waa.v1.Waa/GenerateIT

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:802::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

ESF /

Resource Hash

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	0

Request headers

Accept: */*
Access-Control-Request-Headers: content-type,x-goog-api-key,x-user-agent
Access-Control-Request-Method: POST
Origin: https://www.youtube.com
Sec-Fetch-Mode: cors
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

access-control-allow-credentials: true
access-control-allow-headers: content-type,x-goog-api-key,x-user-agent
access-control-allow-methods: DELETE,GET,HEAD,OPTIONS,PATCH,POST,PUT
access-control-allow-origin: https://www.youtube.com
access-control-max-age: 3600
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 0
content-type: text/html
date: Wed, 13 Mar 2024 07:19:07 GMT
server: ESF
vary: origin referer x-origin
x-content-type-options: nosniff
x-frame-options: SAMEORIGIN
x-xss-protection: 0

POST
H3 200 GenerateIT Show response
jnn-pa.googleapis.com/$rpc/google.internal.waa.v1.Waa/ Frame EBDE 90 B
134 B 19ms
19ms XHR
application/json+protobuf 2a00:1450:4001:802::200a
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://jnn-pa.googleapis.com/$rpc/google.internal.waa.v1.Waa/GenerateIT

Requested by

Host: www.youtube.com
URL: https://www.youtube.com/s/player/704f0391/player_ias.vflset/de_DE/base.js

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:802::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

ESF /

Resource Hash

9c8b2faced8bf64e1d49acb002cf8676e4738ac2c7c81d944510c3e03cb687d4

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	0

Request headers

X-User-Agent: grpc-web-javascript/0.1
Referer: https://www.youtube.com/
X-Goog-Api-Key: AIzaSyDyT5W0Jh49F30Pqqtyfdf7pDLFKLJoAnw
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36
Content-Type: application/json+protobuf

Response headers

date: Wed, 13 Mar 2024 07:19:07 GMT
content-encoding: gzip
x-content-type-options: nosniff
server: ESF
vary: Origin, X-Origin, Referer
x-frame-options: SAMEORIGIN
content-type: application/json+protobuf; charset=UTF-8
access-control-allow-origin: https://www.youtube.com
access-control-expose-headers: vary,vary,vary,content-encoding,date,server,content-length
cache-control: private
access-control-allow-credentials: true
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 110
x-xss-protection: 0

GET
H3 200 styles__ltr.css
www.gstatic.com/recaptcha/releases/QquE1_MNjnFHgZF4HPsEcf_2/ Frame A6A7 55 KB
24 KB 24ms
10ms Stylesheet
text/css 2a00:1450:4001:81c::2003
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.gstatic.com/recaptcha/releases/QquE1_MNjnFHgZF4HPsEcf_2/styles__ltr.css

Requested by

Host: www.google.com
URL: https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC&co=aHR0cHM6Ly9iaW9waGFybWFhcGFjLmNvbTo0NDM.&hl=de&v=QquE1_MNjnFHgZF4HPsEcf_2&size=normal&cb=ez6p3ml2ljab

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:81c::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

7859a62e04b0acb06516eb12454de6673883ecfaeaed6c254659bca7cd59c050

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.google.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Tue, 12 Mar 2024 19:19:12 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 43195
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/recaptcha
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 24606
x-xss-protection: 0
last-modified: Mon, 04 Mar 2024 05:02:47 GMT
server: sffe
cross-origin-opener-policy: same-origin-allow-popups; report-to="recaptcha"
vary: Accept-Encoding
report-to: {"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type: text/css
cache-control: public, max-age=31536000
accept-ranges: bytes
expires: Wed, 12 Mar 2025 19:19:12 GMT

GET
H3 200 recaptcha__de.js Show response
www.gstatic.com/recaptcha/releases/QquE1_MNjnFHgZF4HPsEcf_2/ Frame A6A7 494 KB
196 KB 20ms
6ms Script
text/javascript 2a00:1450:4001:81c::2003
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.gstatic.com/recaptcha/releases/QquE1_MNjnFHgZF4HPsEcf_2/recaptcha__de.js

Requested by

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:81c::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

5564f45c0991c7cceb19c0fb637ee44b119fb14c6cbf3691540a9cad11e1edf3

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.google.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Tue, 12 Mar 2024 22:31:32 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 31655
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/recaptcha
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 200579
x-xss-protection: 0
last-modified: Mon, 04 Mar 2024 05:02:47 GMT
server: sffe
cross-origin-opener-policy: same-origin-allow-popups; report-to="recaptcha"
vary: Accept-Encoding
report-to: {"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type: text/javascript
access-control-allow-origin: *
cache-control: public, max-age=31536000
accept-ranges: bytes
expires: Wed, 12 Mar 2025 22:31:32 GMT

GET
H3 200 styles__ltr.css
www.gstatic.com/recaptcha/releases/QquE1_MNjnFHgZF4HPsEcf_2/ Frame C2CD 55 KB
24 KB 20ms
7ms Stylesheet
text/css 2a00:1450:4001:81c::2003
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.gstatic.com/recaptcha/releases/QquE1_MNjnFHgZF4HPsEcf_2/styles__ltr.css

Requested by

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:81c::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

7859a62e04b0acb06516eb12454de6673883ecfaeaed6c254659bca7cd59c050

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.google.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Tue, 12 Mar 2024 19:19:12 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 43195
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/recaptcha
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 24606
x-xss-protection: 0
last-modified: Mon, 04 Mar 2024 05:02:47 GMT
server: sffe
cross-origin-opener-policy: same-origin-allow-popups; report-to="recaptcha"
vary: Accept-Encoding
report-to: {"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type: text/css
cache-control: public, max-age=31536000
accept-ranges: bytes
expires: Wed, 12 Mar 2025 19:19:12 GMT

GET
H3 200 recaptcha__de.js Show response
www.gstatic.com/recaptcha/releases/QquE1_MNjnFHgZF4HPsEcf_2/ Frame C2CD 494 KB
196 KB 28ms
15ms Script
text/javascript 2a00:1450:4001:81c::2003
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.gstatic.com/recaptcha/releases/QquE1_MNjnFHgZF4HPsEcf_2/recaptcha__de.js

Requested by

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:81c::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

5564f45c0991c7cceb19c0fb637ee44b119fb14c6cbf3691540a9cad11e1edf3

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.google.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Tue, 12 Mar 2024 22:31:32 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 31655
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/recaptcha
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 200579
x-xss-protection: 0
last-modified: Mon, 04 Mar 2024 05:02:47 GMT
server: sffe
cross-origin-opener-policy: same-origin-allow-popups; report-to="recaptcha"
vary: Accept-Encoding
report-to: {"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type: text/javascript
access-control-allow-origin: *
cache-control: public, max-age=31536000
accept-ranges: bytes
expires: Wed, 12 Mar 2025 22:31:32 GMT

GET
H3 200 cast_sender.js Show response
www.gstatic.com/cv/js/sender/v1/ Frame EBDE 4 KB
2 KB 74ms
71ms Script
text/javascript 2a00:1450:4001:81c::2003
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.gstatic.com/cv/js/sender/v1/cast_sender.js

Requested by

Host: www.youtube.com
URL: https://www.youtube.com/s/player/704f0391/player_ias.vflset/de_DE/base.js

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:81c::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

ee147e859ad0f09aa50367974e38ab53e7c7054c4a51d400a7f45b0eb251454f

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.youtube.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Wed, 13 Mar 2024 07:19:07 GMT
content-encoding: gzip
x-content-type-options: nosniff
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/cloudview
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 2007
x-xss-protection: 0
last-modified: Tue, 16 Feb 2021 23:57:06 GMT
server: sffe
cross-origin-opener-policy: same-origin; report-to="cloudview"
vary: Accept-Encoding
report-to: {"group":"cloudview","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/cloudview"}]}
content-type: text/javascript
cache-control: private, max-age=3000
accept-ranges: bytes
expires: Wed, 13 Mar 2024 07:19:07 GMT

GET
H3 204 generate_204
www.youtube.com/ Frame EBDE 0
10 B 6ms
6ms Image
text/plain 2a00:1450:4001:80b::200e
GOOGLE

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.youtube.com/generate_204?_D9llg
Requested by: Host: www.youtube.com
URL: https://www.youtube.com/embed/lOcQEjAN7YU
Protocol: H3
Security: QUIC, , AES_128_GCM
Server: 2a00:1450:4001:80b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software: /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.youtube.com/embed/lOcQEjAN7YU
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Wed, 13 Mar 2024 07:19:07 GMT
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 0

GET
H3 200 Jeg7kAr-4pwBaYwYYQcOgo_iB5tAOGlBo34CkooCo7A.js Show response
www.google.com/js/bg/ Frame C2CD 17 KB
7 KB 9ms
8ms Script
text/javascript 2a00:1450:4001:80b::2004
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.google.com/js/bg/Jeg7kAr-4pwBaYwYYQcOgo_iB5tAOGlBo34CkooCo7A.js

Requested by

Host: www.gstatic.com
URL: https://www.gstatic.com/recaptcha/releases/QquE1_MNjnFHgZF4HPsEcf_2/recaptcha__de.js

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:80b::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

25e83b900afee29c01698c1861070e828fe2079b40386941a37e02928a02a3b0

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC&co=aHR0cHM6Ly9iaW9waGFybWFhcGFjLmNvbTo0NDM.&hl=de&v=QquE1_MNjnFHgZF4HPsEcf_2&size=normal&cb=f20xznm3iu4s
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Wed, 06 Mar 2024 08:14:52 GMT
content-encoding: br
x-content-type-options: nosniff
age: 601455
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/botguard-scs
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 7355
x-xss-protection: 0
last-modified: Mon, 04 Mar 2024 15:30:00 GMT
server: sffe
cross-origin-opener-policy: same-origin; report-to="botguard-scs"
vary: Accept-Encoding
report-to: {"group":"botguard-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/botguard-scs"}]}
content-type: text/javascript
cache-control: public, max-age=31536000
accept-ranges: bytes
expires: Thu, 06 Mar 2025 08:14:52 GMT

GET
H3 200 Jeg7kAr-4pwBaYwYYQcOgo_iB5tAOGlBo34CkooCo7A.js Show response
www.google.com/js/bg/ Frame A6A7 17 KB
7 KB 7ms
6ms Script
text/javascript 2a00:1450:4001:80b::2004
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.google.com/js/bg/Jeg7kAr-4pwBaYwYYQcOgo_iB5tAOGlBo34CkooCo7A.js

Requested by

Host: www.gstatic.com
URL: https://www.gstatic.com/recaptcha/releases/QquE1_MNjnFHgZF4HPsEcf_2/recaptcha__de.js

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:80b::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

25e83b900afee29c01698c1861070e828fe2079b40386941a37e02928a02a3b0

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC&co=aHR0cHM6Ly9iaW9waGFybWFhcGFjLmNvbTo0NDM.&hl=de&v=QquE1_MNjnFHgZF4HPsEcf_2&size=normal&cb=ez6p3ml2ljab
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Wed, 06 Mar 2024 08:14:52 GMT
content-encoding: br
x-content-type-options: nosniff
age: 601455
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/botguard-scs
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 7355
x-xss-protection: 0
last-modified: Mon, 04 Mar 2024 15:30:00 GMT
server: sffe
cross-origin-opener-policy: same-origin; report-to="botguard-scs"
vary: Accept-Encoding
report-to: {"group":"botguard-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/botguard-scs"}]}
content-type: text/javascript
cache-control: public, max-age=31536000
accept-ranges: bytes
expires: Thu, 06 Mar 2025 08:14:52 GMT

GET
H3 200 webworker.js
www.google.com/recaptcha/api2/ Frame C2CD 102 B
134 B 15ms
14ms Other
text/javascript 2a00:1450:4001:80b::2004
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.google.com/recaptcha/api2/webworker.js?hl=de&v=QquE1_MNjnFHgZF4HPsEcf_2

Requested by

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:80b::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

GSE /

Resource Hash

a8bfdecce5d2156da95876601ab50733e863513e3689ce32498a8370e79a5687

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self'
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC&co=aHR0cHM6Ly9iaW9waGFybWFhcGFjLmNvbTo0NDM.&hl=de&v=QquE1_MNjnFHgZF4HPsEcf_2&size=normal&cb=f20xznm3iu4s
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Wed, 13 Mar 2024 07:19:07 GMT
content-encoding: gzip
x-content-type-options: nosniff
content-security-policy: frame-ancestors 'self'
server: GSE
cross-origin-embedder-policy: require-corp
x-frame-options: SAMEORIGIN
report-to: {"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type: text/javascript; charset=utf-8
cache-control: private, max-age=300
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection: 1; mode=block
expires: Wed, 13 Mar 2024 07:19:07 GMT

GET
H3 200 webworker.js
www.google.com/recaptcha/api2/ Frame A6A7 102 B
134 B 15ms
15ms Other
text/javascript 2a00:1450:4001:80b::2004
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.google.com/recaptcha/api2/webworker.js?hl=de&v=QquE1_MNjnFHgZF4HPsEcf_2

Requested by

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:80b::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

GSE /

Resource Hash

a8bfdecce5d2156da95876601ab50733e863513e3689ce32498a8370e79a5687

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self'
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC&co=aHR0cHM6Ly9iaW9waGFybWFhcGFjLmNvbTo0NDM.&hl=de&v=QquE1_MNjnFHgZF4HPsEcf_2&size=normal&cb=ez6p3ml2ljab
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Wed, 13 Mar 2024 07:19:07 GMT
content-encoding: gzip
x-content-type-options: nosniff
content-security-policy: frame-ancestors 'self'
server: GSE
cross-origin-embedder-policy: require-corp
x-frame-options: SAMEORIGIN
report-to: {"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type: text/javascript; charset=utf-8
cache-control: private, max-age=300
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection: 1; mode=block
expires: Wed, 13 Mar 2024 07:19:07 GMT

GET
H3 200 cast_sender.js Show response
www.gstatic.com/eureka/clank/122/ Frame EBDE 50 KB
14 KB 7ms
6ms Script
text/javascript 2a00:1450:4001:81c::2003
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.gstatic.com/eureka/clank/122/cast_sender.js

Requested by

Host: www.gstatic.com
URL: https://www.gstatic.com/cv/js/sender/v1/cast_sender.js

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:81c::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

765a638d2813ec1b917fc56cf90863f88991ef2550c1a14c99e9e9b243e80f74

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.youtube.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Tue, 12 Mar 2024 12:09:12 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 68995
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/cloudview-release
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 14711
x-xss-protection: 0
last-modified: Mon, 15 Jan 2024 16:03:55 GMT
server: sffe
cross-origin-opener-policy: same-origin; report-to="cloudview-release"
vary: Accept-Encoding
report-to: {"group":"cloudview-release","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/cloudview-release"}]}
content-type: text/javascript
cache-control: public, max-age=86400
accept-ranges: bytes
expires: Wed, 13 Mar 2024 12:09:12 GMT

POST
H3 204 rum Show response
biopharmaapac.com/cdn-cgi/ 0
141 B 15ms
15ms XHR
text/plain 2606:4700:3037::6815:6025
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://biopharmaapac.com/cdn-cgi/rum?

Requested by

Host: static.cloudflareinsights.com
URL: https://static.cloudflareinsights.com/beacon.min.js/v84a3a4012de94ce1a686ba8c167c359c1696973893317

Protocol

Security

QUIC, , AES_128_GCM

Server

2606:4700:3037::6815:6025 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Frame-Options	DENY

Request headers

Referer: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36
content-type: application/json

Response headers

date: Wed, 13 Mar 2024 07:19:07 GMT
x-content-type-options: nosniff
server: cloudflare
vary: Origin
access-control-max-age: 86400
access-control-allow-methods: POST,OPTIONS
access-control-allow-origin: https://biopharmaapac.com
x-frame-options: DENY
access-control-allow-credentials: true
cf-ray: 863a4101ce2e37ce-FRA

GET
H3 200 bframe Show response
www.google.com/recaptcha/api2/ Frame A206 7 KB
1 KB 20ms
20ms Document
text/html 2a00:1450:4001:80b::2004
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.google.com/recaptcha/api2/bframe?hl=de&v=QquE1_MNjnFHgZF4HPsEcf_2&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC

Requested by

Host: www.gstatic.com
URL: https://www.gstatic.com/recaptcha/releases/QquE1_MNjnFHgZF4HPsEcf_2/recaptcha__de.js

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:80b::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

GSE /

Resource Hash

35edd33dbd59ee6770db64a9d14dbea7250a267a95182cf48bded38341a85f1f

Security Headers

Name	Value
Content-Security-Policy	script-src 'report-sample' 'nonce-9JFKtSavrQn6GRBvD0r11A' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
X-Content-Type-Options	nosniff
X-Xss-Protection	1; mode=block

Request headers

Referer: https://biopharmaapac.com/
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36
accept-language: de-DE,de;q=0.9

Response headers

alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control: no-cache, no-store, max-age=0, must-revalidate
content-encoding: gzip
content-security-policy: script-src 'report-sample' 'nonce-9JFKtSavrQn6GRBvD0r11A' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
content-type: text/html; charset=utf-8
cross-origin-embedder-policy: require-corp
cross-origin-resource-policy: cross-origin
date: Wed, 13 Mar 2024 07:19:07 GMT
expires: Mon, 01 Jan 1990 00:00:00 GMT
pragma: no-cache
report-to: {"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
server: GSE
x-content-type-options: nosniff
x-xss-protection: 1; mode=block

GET
H3 200 bframe Show response
www.google.com/recaptcha/api2/ Frame 9D16 7 KB
1 KB 18ms
18ms Document
text/html 2a00:1450:4001:80b::2004
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.google.com/recaptcha/api2/bframe?hl=de&v=QquE1_MNjnFHgZF4HPsEcf_2&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC

Requested by

Host: www.gstatic.com
URL: https://www.gstatic.com/recaptcha/releases/QquE1_MNjnFHgZF4HPsEcf_2/recaptcha__de.js

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:80b::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

GSE /

Resource Hash

2e5e49c49be368919231b2cc49cb16fdbca43c17815e99956f775f14e0b242f9

Security Headers

Name	Value
Content-Security-Policy	script-src 'report-sample' 'nonce-lnB41TX0HQfMUZHHiCrYig' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
X-Content-Type-Options	nosniff
X-Xss-Protection	1; mode=block

Request headers

Referer: https://biopharmaapac.com/
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36
accept-language: de-DE,de;q=0.9

Response headers

alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control: no-cache, no-store, max-age=0, must-revalidate
content-encoding: gzip
content-security-policy: script-src 'report-sample' 'nonce-lnB41TX0HQfMUZHHiCrYig' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
content-type: text/html; charset=utf-8
cross-origin-embedder-policy: require-corp
cross-origin-resource-policy: cross-origin
date: Wed, 13 Mar 2024 07:19:07 GMT
expires: Mon, 01 Jan 1990 00:00:00 GMT
pragma: no-cache
report-to: {"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
server: GSE
x-content-type-options: nosniff
x-xss-protection: 1; mode=block

GET
H3 200 styles__ltr.css
www.gstatic.com/recaptcha/releases/QquE1_MNjnFHgZF4HPsEcf_2/ Frame 9D16 55 KB
24 KB 6ms
6ms Stylesheet
text/css 2a00:1450:4001:81c::2003
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.gstatic.com/recaptcha/releases/QquE1_MNjnFHgZF4HPsEcf_2/styles__ltr.css

Requested by

Host: www.google.com
URL: https://www.google.com/recaptcha/api2/bframe?hl=de&v=QquE1_MNjnFHgZF4HPsEcf_2&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:81c::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

7859a62e04b0acb06516eb12454de6673883ecfaeaed6c254659bca7cd59c050

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.google.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Tue, 12 Mar 2024 19:19:12 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 43195
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/recaptcha
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 24606
x-xss-protection: 0
last-modified: Mon, 04 Mar 2024 05:02:47 GMT
server: sffe
cross-origin-opener-policy: same-origin-allow-popups; report-to="recaptcha"
vary: Accept-Encoding
report-to: {"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type: text/css
cache-control: public, max-age=31536000
accept-ranges: bytes
expires: Wed, 12 Mar 2025 19:19:12 GMT

GET
H3 200 recaptcha__de.js Show response
www.gstatic.com/recaptcha/releases/QquE1_MNjnFHgZF4HPsEcf_2/ Frame 9D16 494 KB
196 KB 7ms
7ms Script
text/javascript 2a00:1450:4001:81c::2003
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.gstatic.com/recaptcha/releases/QquE1_MNjnFHgZF4HPsEcf_2/recaptcha__de.js

Requested by

Host: www.google.com
URL: https://www.google.com/recaptcha/api2/bframe?hl=de&v=QquE1_MNjnFHgZF4HPsEcf_2&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:81c::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

5564f45c0991c7cceb19c0fb637ee44b119fb14c6cbf3691540a9cad11e1edf3

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.google.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Tue, 12 Mar 2024 22:31:32 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 31655
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/recaptcha
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 200579
x-xss-protection: 0
last-modified: Mon, 04 Mar 2024 05:02:47 GMT
server: sffe
cross-origin-opener-policy: same-origin-allow-popups; report-to="recaptcha"
vary: Accept-Encoding
report-to: {"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type: text/javascript
access-control-allow-origin: *
cache-control: public, max-age=31536000
accept-ranges: bytes
expires: Wed, 12 Mar 2025 22:31:32 GMT

GET
H3 200 styles__ltr.css
www.gstatic.com/recaptcha/releases/QquE1_MNjnFHgZF4HPsEcf_2/ Frame A206 55 KB
24 KB 7ms
7ms Stylesheet
text/css 2a00:1450:4001:81c::2003
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.gstatic.com/recaptcha/releases/QquE1_MNjnFHgZF4HPsEcf_2/styles__ltr.css

Requested by

Host: www.google.com
URL: https://www.google.com/recaptcha/api2/bframe?hl=de&v=QquE1_MNjnFHgZF4HPsEcf_2&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:81c::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

7859a62e04b0acb06516eb12454de6673883ecfaeaed6c254659bca7cd59c050

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.google.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Tue, 12 Mar 2024 19:19:12 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 43195
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/recaptcha
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 24606
x-xss-protection: 0
last-modified: Mon, 04 Mar 2024 05:02:47 GMT
server: sffe
cross-origin-opener-policy: same-origin-allow-popups; report-to="recaptcha"
vary: Accept-Encoding
report-to: {"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type: text/css
cache-control: public, max-age=31536000
accept-ranges: bytes
expires: Wed, 12 Mar 2025 19:19:12 GMT

GET
H3 200 recaptcha__de.js Show response
www.gstatic.com/recaptcha/releases/QquE1_MNjnFHgZF4HPsEcf_2/ Frame A206 494 KB
196 KB 8ms
8ms Script
text/javascript 2a00:1450:4001:81c::2003
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.gstatic.com/recaptcha/releases/QquE1_MNjnFHgZF4HPsEcf_2/recaptcha__de.js

Requested by

Host: www.google.com
URL: https://www.google.com/recaptcha/api2/bframe?hl=de&v=QquE1_MNjnFHgZF4HPsEcf_2&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:81c::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

5564f45c0991c7cceb19c0fb637ee44b119fb14c6cbf3691540a9cad11e1edf3

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.google.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36

Response headers

date: Tue, 12 Mar 2024 22:31:32 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 31655
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/recaptcha
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 200579
x-xss-protection: 0
last-modified: Mon, 04 Mar 2024 05:02:47 GMT
server: sffe
cross-origin-opener-policy: same-origin-allow-popups; report-to="recaptcha"
vary: Accept-Encoding
report-to: {"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type: text/javascript
access-control-allow-origin: *
cache-control: public, max-age=31536000
accept-ranges: bytes
expires: Wed, 12 Mar 2025 22:31:32 GMT

POST
H3 200 log_event Show response
www.youtube.com/youtubei/v1/ Frame EBDE 28 B
50 B 20ms
20ms XHR
application/json 2a00:1450:4001:80b::200e
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.youtube.com/youtubei/v1/log_event?alt=json&key=AIzaSyAO_FJ2SlqU8Q4STEHLGCilw_Y9_11qcW8

Requested by

Host: www.youtube.com
URL: https://www.youtube.com/s/player/704f0391/www-embed-player.vflset/www-embed-player.js

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:80b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

scaffolding on HTTPServer2 /

Resource Hash

d7d5e54ad1e33d7ab49c664323ced79cb9723ff15e9764cd0edc3e15208e8336

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36
X-Goog-Request-Time: 1710314349524
Content-Type: application/json
X-YouTube-Utc-Offset: 60
X-YouTube-Client-Name: 56
Referer: https://www.youtube.com/embed/lOcQEjAN7YU
X-YouTube-Client-Version: 1.20240310.00.00
X-YouTube-Time-Zone: Europe/Berlin
X-Goog-Visitor-Id: CgtSTGFMUnVhMDRQRSjrpsWvBjIKCgJERRIEEgAgOw%3D%3D
X-YouTube-Ad-Signals: dt=1710314347391&flash=0&frm=2&u_tz=60&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&bc=31&bih=-12245933&biw=-12245933&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C350%2C200&vis=1&wgl=true&ca_type=image

Response headers

date: Wed, 13 Mar 2024 07:19:09 GMT
content-encoding: br
x-content-type-options: nosniff
server: scaffolding on HTTPServer2
x-frame-options: SAMEORIGIN
vary: Origin, X-Origin, Referer
content-type: application/json; charset=UTF-8
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 31
x-xss-protection: 0

Verdicts & Comments Add Verdict or Comment

42 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

6 Cookies

Cookies are little pieces of information stored in the browser of a user. Whenever a user visits the site again, he will also send his cookie values, thus allowing the website to re-identify him even if he changed locations. This is how permanent logins work.

Domain/Path	Expires	Name / Value
biopharmaapac.com/	1969-12-31 23:59:59	Name: PHPSESSID Value: smjqno7d9gc1od8dulsq0ntvs0
.youtube.com/	1969-12-31 23:59:59	Name: YSC Value: 8S8PRlNMyWI
.youtube.com/	1970-01-20 23:24:26	Name: VISITOR_INFO1_LIVE Value: RLaLRua04PE
.youtube.com/	1970-01-20 23:24:26	Name: VISITOR_PRIVACY_METADATA Value: CgJERRIEEgAgOw%3D%3D
.biopharmaapac.com/	1970-01-21 04:41:14	Name: _ga_2E2BXNMKP4 Value: GS1.1.1710314347.1.0.1710314347.0.0.0
.biopharmaapac.com/	1970-01-21 04:41:14	Name: _ga Value: GA1.1.270205643.1710314348

24 Console Messages

A page may trigger messages to the console to be logged. These are often error messages about being unable to load a resource or execute a piece of JavaScript. Sometimes they also provide insight into the technology behind a website.

Source	Level	URL Text
other	warning	URL: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren(Line 918) Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren(Line 918) Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren(Line 918) Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren(Line 918) Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren(Line 918) Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren(Line 918) Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren(Line 918) Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren(Line 918) Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren(Line 918) Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren(Line 918) Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren(Line 918) Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren(Line 918) Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren Message: Third-party cookie will be blocked. Learn more in the Issues tab.
other	warning	URL: https://biopharmaapac.com/news/134/4445/carsgen-therapeutics-receives-nmpa-approval-for-breakthrough-multiple-myeloma-car-t-cell-therapy.html?__s=5slvqff6wv2m7m6e2l9i&utm_source=drip&utm_medium=email&utm_campaign=Innovating+for+Health+Equity%3A+Takeda%27s+Blueprint+for+Medicine+Access+in+APAC+with+Dion+Warren Message: Third-party cookie will be blocked. Learn more in the Issues tab.

Security Headers

This page lists any security headers set by the main page. If you want to understand what these mean and how to use them, head on over to this page

Header	Value
Content-Security-Policy	upgrade-insecure-requests

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

biopharmaapac.com
fonts.gstatic.com
googleads.g.doubleclick.net
i.ytimg.com
jnn-pa.googleapis.com
platform.twitter.com
region1.google-analytics.com
static.cloudflareinsights.com
static.doubleclick.net
syndication.twitter.com
t.dripemail2.com
www.google.com
www.googletagmanager.com
www.gstatic.com
www.youtube.com
yt3.ggpht.com
104.244.42.8
199.232.188.157
2001:4860:4802:32::36
2606:4700:3037::6815:6025
2606:4700::6810:5049
2a00:1450:4001:802::200a
2a00:1450:4001:80b::2003
2a00:1450:4001:80b::2004
2a00:1450:4001:80b::200e
2a00:1450:4001:80e::2008
2a00:1450:4001:811::2001
2a00:1450:4001:81c::2003
2a00:1450:4001:828::2006
2a00:1450:4001:829::2002
2a00:1450:4001:82a::2016
34.238.102.32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biopharmaapac.com Open in urlscan Pro 2606:4700:3037::6815:6025 Public Scan

Summary

urlscan.io Verdict: No classification

Domain & IP information

Screenshot Live screenshot Full Image

Page Title

Page URL History Show full URLs

Detected technologies

Page Statistics

77 Requests

99 %HTTPS

81 %IPv6

13 Domains

16 Subdomains

16 IPs

2 Countries

4512 kBTransfer

9500 kBSize

6 Cookies

9 Outgoing links

Page URL History

Redirected requests

77 HTTP transactions Everything HTML Script AJAX CSS Image Expand all 1 data transactions

Request headers

Response headers

Redirect headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

biopharmaapac.com Open in urlscan Pro
2606:4700:3037::6815:6025 Public Scan

Screenshot
Live screenshot

Full Image

77
Requests

99 %
HTTPS

81 %
IPv6

13
Domains

16
Subdomains

16
IPs

2
Countries

4512 kB
Transfer

9500 kB
Size

6
Cookies

77 HTTP transactions
1 data transactions